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8Suomenkielinen tiivistelmä
Lastenreuman perimmäiset syyt ovat yhä tuntemattomat. Se on monitekijäinen sairaus 
ja nykykäsityksen mukaan sen syntyyn vaikuttavat sekä perintö- että ympäristöteki-
jät. Sekä geneettiset että ympäristötekijät vaikuttavat taudin ja sen alatyyppien esiin-
tyvyyden eroihin eri väestöissä ja roduilla. Perintötekijöiden osuutta sairastavuuteen 
vahvistaa taudin suvuittainen kertyminen sekä kaksosaineistossa todettu konkordanssi. 
Lisäksi lastenreuman assosiotuminen tiettyihin kromosomi kuuden HLA-polymorfi s-
meihin vahvistaa geneettisen komponentin osuutta.
Perintötekijöiden etsinnässä lastenreumaa sairastavien potilaiden verinäytteistä 
määritellyistä markkereiden genotyyppitiedoista pyritään selvittämään mahdollista 
kytkeytymistä tautia aiheuttavaan geeniin. Aikaisemmissa tutkimuksissa vahvin las-
tenreumalle altistava geenialue näyttää koko genomin kattavan analyysin perusteella 
sijoittuvan HLA-alueelle, mutta muillakin genomin alueiden geeneillä on ilmeisesti vai-
kutusta.
Suomalaisten geneettisiltä taustoiltaan homogeenisten potilaiden tutkiminen mah-
dollistaa monitekijäisten tautien, kuten lastenreuman tautikytkentöjen selvittämisen 
pienemmästäkin potilasmäärästä, koska (1) kytkentäepätasapainon uskotaan käsittä-
vän suurempia kromosomipalasia ja (2) on todennäköistä, että suppeassa ns. perustaja-
väestössä on altistavia geenejä rajoitetusti.
Tässä väitöskirjatutkimuksessa tutkittiin lastenreuman suvuittaista kertymistä ja 
HLA alleeli assosiaatioita kytkentä- ja assosiaatioanalyyseilla Reumasäätiön sairaalan 
sisaruspari-aineistossa.Väitöstutkimuksen tulokset osoittavat, että lastenreuman periy-
tyvyys on selvästi voimakkaampaa kuin aikuisten nivelreumassa. Monotsygoottisten, 
perimältään identtisten kaksosten aineistossa todettiin, että 25 %:ssa kumpikin kaksos-
parin jäsen sairasti lastenreumaa. Tätä verrattaessa lastenreuman esiintyvyyteen väes-
tössä (1/1000) identtisen kaksosen riski sairastua, jos toisella on lastenreuma, on 250-
kertainen. Muiden sisrusten sairastumisriski on arviolta n. 15–20 kertainen.
Lastenreumaan usein liittyvän silmän värikalvotulehduksen esiintyvyys molemmilla 
sisaruspareilla ei poikennut odotetusta eikä selvää geneettistä tekijää tälle silmäkompli-
kaatiolle voitu osoittaa.
Lastenreumaa sairastavien sisarusten vanhemmilla todettiin odotettua enemmän 
kroonisia tulehduksellisia reumasairauksia, jotka joko olivat alkaneet vanhemmillakin 
jo lapsuudessa tai sitten ne kliiniseltä kuvaltaan sekä HLA-alleeliesiintyvyyden perus-
teella olivat lastenreuman kaltaisia.
Väitöstutkimuksessa määritettiin HLA-haplotyyppejä suomalaisilta lastenreumaa 
sairastavilta potilailta. Assosiaatioanalyysien tulokset vahvistivat taudille ainakin osit-
tain altistavien geenien periytyvän yhdessä DRB1*08, DQB1*04 sekä Cw*04 alleelin 
kanssa.
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Genetic susceptibility to juvenile idiopathic arthritis (JIA) was studied in the genetic-
ally homogeneous Finnish population by collecting families with two or three patients 
aff ected by this disease from cases seen in the Rheumatism Foundation Hospital. Th e 
number of families ranged in diff erent studies from 37 to 45 and the total number of pa-
tients with JIA, from among whom these cases were derived, was 2 000 to 2 300. Charac-
teristics of the disease in aff ected siblings in Finland were compared with a population-
based series and with a sibling series from the United States. A thorough clinical and 
ophthalmological examination was made of all aff ected patients belonging to sibpair 
series. Information on the occurrence of chronic rheumatic diseases in parents was col-
lected by questionnaire and diagnoses were confi rmed from hospital records.
All patients, their parents and most of the healthy sibs were typed for human leuko-
cyte antigen (HLA) alleles in loci A, C, B, DR and DQ. Th e HLA allele distribution of 
the cases was compared with corresponding data from Finnish bone marrow donors. 
Th e genetic component in JIA was found to be more signifi cant than previously be-
lieved. A concordance rate of 25% for a disease with a population prevalence of 1 per 
1000 implied a relative risk of 250 for a monozygotic (MZ) twin. An estimate for the 
sibling risk of an aff ected individual was about 15- to 20-fold.
Th e disease was basically similar in familial and sporadic cases; the mean age at dis-
ease onset was however lower in familial cases, (4.8 years vs 7.4 years). Th ree sibpairs 
(3.4 expected) were concordant for the presence of asymptomatic uveitis. Uveitis would 
thus not appear to have any genetic component of its own, separate from the genetic 
basis of JIA. Four of the parents had JIA (0.2 cases expected), four had a type of rheuma-
toid factor-negative arthritis similar to that seen in juvenile patients but commencing in 
adulthood, and one had spondyloarthropathy (SPA). Th ese fi ndings provide additional 
support for the conception of a genetic predisposition to JIA and suggest the existence 
of a new disease entity, JIA of adult onset.
Both the linkage analysis of the aff ected sibpairs and the association analysis of nu-
clear families provided overwhelming evidence of a major contribution of HLA to the 
genetic susceptibility to JIA. Th e association analysis in the Finnish population con-
fi rmed that the most signifi cant associations prevailed for DRB1*0801, DQB1*0402, as 
expected from previous observations, and indicated the independent role of Cw*0401.
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ACR American College of Rheumatology
AG Antigen
ANA Antinuclear antibodies
ARA American Rheumatism Association
AS Ankylosing spondylitis
ASP Aff ected sibpair
β2-m β2-microglobulin
CI Confi dence interval
DZ Dizygotic
ESR Erythrocyte sedimentation rate
EULAR European League of Associations of Rheumatology
HLA Human leukocyte antigen
ILAR International League of Associations of Rheumatology
JCA Juvenile chronic arthritis
JIA Juvenile idiopathic arthritis
JRA Juvenile rheumatoid arthritis
λs sibling recurrence ratio
LOD logarithm of odds
MHC Major histocompatibility complex
MZ Monozygotic
RA Rheumatoid arthritis
RF Rheumatoid factor
SBT Sequence-based typing
SD Standard deviation
SNP Single nucleotide polymorphism
SPA Spondyloarthropathy
SSP Sequence-specifi c primer
TCR T cell receptor
TDT Transmission disequilibrium test
TNF Tumor necrosis factor
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Introduction
Chronic arthritis of childhood comprises heterogeneous group of disease conditions of 
unknown cause. Characteristic for them is infl ammation in one or more joints, together 
with occasional manifestations in other organ systems. Some disease types such as oligo-
arthritis with associated chronic uveitis are seen mainly in children, whereas certain 
other types are seen both in children and in adults, although their respective clinical 
phenotypes may diff er to some degree.
Th e overall incidence of chronic arthritides of childhood is only one-tenth of that 
of rheumatoid arthritis (RA) in adults. Nevertheless juvenile patients frequently live 
some 60–70 years with their disease. Th e life-long burden caused by the disease is thus 
considerable both for the individual and for society.
George Fredrich Still described chronic arthritis in childhood in his publication ‘On 
a form of chronic joint disease in children’ (Still 1897). Aft er recognising childhood 
arth ritis as distinct from chronic arthritis in adults, Still was the fi rst author to draw at-
tention to the heterogeneity of childhood chronic arthritis, and juvenile-onset chronic 
arth ritis has since been thought to be more than one disease. Still also described a spe-
cifi c subgroup of childhood arthritis characterized by an acute onset of disease, where 
the patient in addition to arthritis had lymphadenopathy, splenomegaly, fever and peri-
carditis. In early days all chronic arthritides in children were called Still’s disease, wher-
was nowadays this term is reserved for the systemic form of the disease.
Much work has been done to determine the genetic contribution to childhood 
chronic arthritis. Th e relevant evidence comes mainly from observations of associations 
of human leukocyte antigen (HLA) with certain forms of arthritis. Th e genetic associa-
tions with HLA seem to vary according to disease subtypes. Few family or sibling series 
have hitherto been published, but as the basic populations from which these cases were 
derived are only poorly known, it is diffi  cult to draw any conclusion from these studies 
as to the overall magnitude of the genetic component.
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Review of the literature
1 Defi nition and classifi cation
In the 1970s two sets of criteria were introduced for the diagnosis and classifi cation of 
childhood chronic arthritis, those proposed by a committee of Th e American Rheuma-
tism Association (ARA), and those by a committee of Th e European League of Associa-
tions of Rheumatology (EULAR). Th e main diff erences between these two sets of criteria 
are the requirement concerning the duration of arthritis necessary for diagnosis and the 
subsets of the disease included.
1.1 Juvenile rheumatoid arthritis
ARA, subsequently Th e American College of Rheumatology (ACR) Criteria Subcommit-
tee published in 1972 the initial criteria for the classifi cation of children with juvenile 
rheumatoid arthritis (JRA). Th e minimum duration of arthritis necessary for diagnosis 
was set at 6 weeks (Brewer et al.1972). Modifi cations of the original criteria were de-
veloped in 1976 to place greater emphasis on subgroups according to the onset type of 
the disease: systemic, polyarticular and pauciarticular (Brewer et al. 1977). A further 
subdivision was made according to the course of the disease aft er the onset period of six 
months (Cassidy et al. 1986).
1.2 Juvenile chronic arthritis
At a workshop arranged by EULAR in 1977 the term juvenile chronic arthritis (JCA) was 
proposed (Wood 1978). JCA was defi ned as an arthritis persisting for at least 3 months. 
Th e following subgroups were distinguished according to the EULAR criteria: rheuma-
toid factor (RF)-negative chronic arthritis, which includes systemic, polyarticular and 
pauciarticular disease, and RF-positive polyarticular disease. JCA also includes children 
with juvenile ankylosing spondylitis (AS), psoriatic arthropathy and the arthropathies 
associated with infl ammatory bowel disease, whereas the ACR criteria do not cover 
these subsets.
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1.3 Juvenile arthritis
Th e term juvenile arthritis has sometimes been used to encompass a wider range of 
arthritic conditions than those covered by the ACR and EULAR criteria, but the term 
has not been generally accepted and remains controversial (Cassidy and Nelson 1988; 
Cassidy et al. 1989).
1.4 Juvenile idiopathic arthritis
Th e ACR criteria widely used in North and South America and the EULAR criteria 
primarily used by European investigators are not wholly interchangeable. Th is lack of 
uniformity led to an attempt to standardize the diagnostic and classifi cation criteria 
worldwide. Along these lines, the Classifi cation Taskforce of the Pediatric Standing 
Committee of Th e International League of Associations of Rheumatology (ILAR) pro-
posed a classifi cation system with special emphasis on defi ning homogeneous sub-
groups (Fink 1995). Th e term suggested for the disease was juvenile idiopathic arthritis 
(JIA) according to the Durban criteria (Petty et al. 1998). A minor revision of the criteria 
was recently published (Petty et al. 2004).
Th e basic requirements are arthritis in one or more joints, persisting for at least 6 
weeks and onset before the 16th birthday. Th e disease is divided into seven subtypes: 
systemic arthritis, polyarticular form positive and negative for RF, oligoarthritis (per-
sistent and extended oligoarthritis), enthesitis-related arthritis, and psoriatic arthritis. 
In addition, a category termed ‘other’ comprises children who do not fi t into any of the 
above categories or who fi t into more than one. A new disease group, extended oligo-
arthritis, covers a group of patients in whom the pattern of arthritis alters from an initial 
oligoarthritis to polyarthritis. In addition, certain extra-articular clinical features are 
used for the classifi cation of enthesitis-related arthritis and psoriatic arthritis. Th e term 
enthesitis-related arthritis is more useful than those previously employed, for example 
juvenile AS, because few children in fact evince radiographic changes in the sacroiliac 
joints or defi nite signs of AS in their spine before 16 years of age. Th is subgroup was 
described as early as 1982 by Rosenberg and Petty in their work on the RF-negative 
enthesopathy and arthropathy syndrome (Rosenberg and Petty 1982); they recognized 
it as a juvenile manifestation of AS. Th e subgroup psoriatic arthritis is more useful as 
a separate entity rather than being lumped into a spondyloarthropathy group, since 
juvenile psoriatic arthritis may present with diff erent joint patterns; only a minority of 
patients have axial involvement, and few are HLA B27-positive.
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1.5 Juvenile idiopathic arthritis versus adult rheumatoid arthritis
Th e subtype of RF-positive polyarthritis is considered to be the pediatric equivalent of 
adult rheumatoid arthritis; indeed, this subtype shares genetic markers with adult RA 
(Moore et al. 1984; Vehe et al. 1990). Systemic onset JIA can sometimes occur in adults, 
and is referred to as ‘adult-onset Still’s disease’. A subtype which has been thought to 
occur exclusively in children is oligoarthritis beginning in early years, oft en associated 
with chronic anterior uveitis. Th is disease subtype has been the subject of the largest 
number of HLA studies and is genetically the best defi ned entitity (Fernendez-Viña 
et al. 1994). A proportion of RF-negative polyarthritis is possibly related to the RF-
negative RA of adults, on the basis of certain genetic links which they are reported to 
have in common (Gao et al. 1991).
Th e various concepts used to classify chronic arthritis in childhood have mainly 
emerged through clinical features. Some serological features have been used for further 
subclassifi cation without any offi  cial recommendations until those made by ILAR crite-
ria comittee (Petty et al. 2004). A list of additional features, called descriptions, such as 
the presence of antinuclear antibodies (ANA), do not form a part of the classifi catin as 
such, but may be important indicators of outcome. Th e diff erent terms used for chronic 
arthritis in childhood and their contents are set out in Table 1.
2 Occurrence of juvenile idiopathic arthritis
Data published on the incidence and prevalence of JIA have shown marked variation, 
which can be accounted for by diff erences in the diagnostic criteria used, the nature of 
the population studied, the number of patients and sizes of the populations on which 
the fi gures are based, methods of patient retrieval, and the length of the period studied. 
Th e ideal approach might be prospective population-based studies of well-defi ned dis-
ease groups from diff erent geographical areas and in populations with diff erent genetic 
backgrounds.
Th e diff erent methodologies used for case identifi cation include population-based 
cohorts, practitioner surveys, clinic-based studies (in which case identifi cation is made 
in pediatric rheumatology specialty clinics), and disease registers. Population surveys 
have yielded the highest rates, followed by practitioner surveys, whereas the lowest 
numbers have been obtained from clinic-based studies, where the proportion of severe 
cases is fairly high and the studies in question have missed a notable proportion of mild 
cases (Oen and Cheang 1996). 
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2.1 Prevalence
Based on reliable data, the prevalence of JIA in the pediatric population has been esti-
mated to be about 100/100 000 from suffi  ciently extensive studies (Manners and Bower 
2002; Andersson Gäre 1999; Towner et al. 1983; Moe and Rygg 1998; Andersson Gäre 
and Fasth 1992). Nonetheless wide variations in prevalence have been reported from 
diff erent geographical locations, ranging from 8 to 400/100 000 in the pediatric popu-
lation (Table 2). Th e lowest estimate, 8/100 000, is from one region in France and was 
Table 1 A comparison of the sets of criteria used for chronic arthritis in childhood.
Defi nition Classifi cation for chronic juvenile arthritis
Juvenile 
chronic 
arthritis
Juvenile 
rheumatoid 
arthritis
Juvenile 
idiopathic           
arthritis
Criteria (term) EULAR (JCA) ACR (JRA) ILAR (JIA)
Time Disease 
duration
Th ree months Six weeks Six weeks
Clinical 
features
Arthritis 
type:
Poly 
Oligo
Systemic
Psoriatic
Juvenile ankylosing 
spondylitis
Arthritis in 
connection with 
infl ammatory 
bowel disease
Poly
Oligo
Systemic
Poly
Oligo:
 persistent 
 extended
Systemic
Psoriatic
Enthesitis-
related
Other
Serological 
features
Rheumatoid 
factor
Subclassifi cation: 
RF-positive: 
juvenile 
rheumatoid 
arthritis
Subclassifi cation: 
RF-positive 
polyarthritis
A criterion for 
RF-positive 
polyarthritis
HLA-B27 Not considered Not considered A criterion 
for enthesitis-
related arthritis
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probably infl uenced by patient selection; it is possible that a considerable proportion of 
mild cases were not reported (Prieur et al. 1987). Th e highest prevalence, 400/100 000, 
was reported in a study from Australia where case ascertainment was based on popula-
tion questionnaires in combination with clinical examination by a pediatric rheuma-
tologist (Manners and Diepeveen 1996). 
2.2 Incidence
Th e worldwide annual incidence of JIA is reported as 0.8 to 22.6 per 100 000 children 
from areas where reliable data are available (Table 2) (Manners and Bower 2002). Lower 
fi gures may have been infl uenced by fl aws in methodology. Th us, both the Finnish 
study by Laaksonen and associates (1966), which reported a very low incidence fi gure, 
3.8/100 000, and the Japanese study by Fujikawa and Okuni (1997), reporting an annual 
incidence of 0.8/100 000, covered hospital cases only.
Th e incidence of JIA in Finland reported in recent studies by Kaipiainen Seppänen 
and Savolainen (1996, 2001) ranged from 13.5 to 19.5/100 000. Th e average age of JIA 
onset is around 7–8 years and if the disease is persistent, the duration (to age 16) is 
around 8 years. Th us according to incidence fi gures, the prevalence fi gures in Finland 
would be about 108–156/100 000.
Diff erences in the occurrence of JIA have been reported between patient groups de-
pending on their ethnic and geographic background. Th ese variations may result either 
from genetic or from environmental infl uences. In population-based studies with a 
Caucasian dominance, the incidence of JIA has ranged from 10 to 23 per 100 000 (Bernt-
son et al. 2003; Andersson Gäre 1999). A clearly lower occurrence has been reported 
in a Hispanic population, an incidence of 6.8 per 100 000 (Arguedas et al. 1998) and in 
African American children, in whom the frequency of the oligoarticular subtype (34.3% 
vs 54.7% in Caucasian children) and the presence of antinuclear antibodies (ANA) in 
oligoarticular JIA patients (33.3% vs 70.7%) were also less common than in their Cau-
casian counterparts (Schwartz et al. 1997). 
A tendency toward a decreasing north to south gradient in incidence has been noted 
in Europe. No such gradient would appear to exist in North America (Andersson Gäre 
1999). Th e high incidence rates reported from Scandinavian countries may be a true 
phenomenon based on genetic or environmental factors. Interestingly, the incidence 
of another important autoimmune childhood disease, type 1 diabetes, is also high in 
Nordic countries, especially in Finland.
A cyclical pattern of incidence reported from North America and Finland suggests 
a role of environmental infl uences. Peterson and colleagues (1996) found an overall de-
crease in the incidence of JIA during 1960–1993 in Rochester, Minnesota, especially in 
the case of the oligoarticular and systemic onset types. On the other hand, Kaipiainen-
Seppänen and Savolainen (1996) reported a slight increase in the incidence of oligo- 
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and polyarticular groups of disease in 1995 compared to the years 1980, 1985 and 1990, 
while no such increase was observed in the systemic group. Seasonal variation reported 
in incidence studies concerning systemic JIA suggests the role of environmental triggers 
such as infections (Lindsley1987; Peterson et al. 1996). 
Table 2 Incidence and prevalence of JIA, lowest and highest fi gures reported in diff erent 
populations.
Reference 
(fi rst author) Population
Diagnostic
criteria
Incidence
(100 000/year)
Prevalence
(/100 000)
Laaksonen (1966) Finland Other* 3.8 ND†
Towner (1983) Minnesota, USA ARA
EULAR
13.9 (1960–79)
10.8
113
84
Kunnamo (1986) Finland ARA 19.6 (1982–83) ND
Prieur (1987) France EULAR 1.3–1.9 (1981–82) 8–10
Andersson Gäre (1992) Sweden EULAR 10.9 (1984–88) 86.3
Kaipiainen-Seppänen 
(1996)
Finland ARA 13.8 (1980)
15.1 (1985)
13.5 (1990)
ND
Symmons (1996) UK EULAR 10 (1990–95) ND
Peterson (1996) Minnesota, USA ARA 15.0 (1960–69)
14.1 (1970–79)
7.8 (1980-93)
94.3 (1980) 
86.1 (1990)
Manners (1996) Australia EULAR ND 400
Fujikawa (1997) Japan ARA 0.8 (1994) ND
Moe (1998) Norway EULAR 22.6 (1985–94) 148
Arguedas (1998) Costa Rica 
(Hispanic, 
American Indian)
EULAR 6.8 (1993–95) 34.9
Kaipiainen-Seppänen 
(2001)
Finland ARA 19.5 (1995) ND
* ARA or EULAR criteria not used at that time.  † Not done. 
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3 Clinical features and course of juvenile idiopathic arthritis
3.1 Systemic onset juvenile arthritis
Systemic features are most prominent in the early phase of systemic onset juvenile arth-
ritis. Th ey include high, intermittent fever, typical papulomacular rash and visceral 
involvements such as hepatosplenomegaly, lymphadenopathy, pericarditis or other 
evidence of serositis. Th ese features, which are typically intermittent, persisting from 
a minimum of 2 weeks up to 5 years at the longest, gradually vanish. Children may 
have signifi cant arthralgias and myalgias or even arthritis during the febrile period, 
but the development of overt arthritis is necessary for a diagnosis of systemic arthritis. 
Arthritis may be oligoarticular or polyarticular. Typical laboratory fi ndings are elevated 
white cell and platelet counts and a high erythrocyte sedimentation rate (ESR). Serum 
ferritin levels are of diagnostic value for the disease and refl ect the response of the fever 
to treatment (Pelkonen et al. 1986). RF and ANA are usually absent. Th e peak age at 
onset is 2 years and the disease occurs with almost equal frequency in boys and girls 
(Woo and Wedderburn 1998). In some children, the systemic phase lasts from only a 
few months to several years, but others have recurring episodes or persistent systemic 
manifest ations. Important for the outcome is the type of arthritis, which is more favora-
ble in patients with oligoarthritis compared with the polyarticular form.
3.2 Polyarthritis, rheumatoid factor-positive/-negative
In polyarticular juvenile arthritis fi ve or more joints are aff ected within the fi rst 6 
months aft er onset. Most of the children in question have symmetric arthritis of knees, 
ankles, wrists, elbows and shoulders, and the cervical spine is oft en involved in this type 
of disease. Temporomandibular joint arthritis is relatively common in children with 
polyarthritis (Cassidy and Petty 2001).
Polyarticular RF-positive JIA is predominantly a disease of teenage girls. Some of 
the prominent features are rapid progression and severity of the arthritis, aff ecting espe-
cially small joints and leading to early erosions. Th e severity of RF-positive polyarthritis 
is about the same as that of the polyarticular type of systemic onset disease (Cassidy et 
al. 1989). 
RF-negative polyarthritis occurs in children at all ages, with two peaks, one at 2 to 
3 years and another at preadolescent age. Th e proportion of boys is higher than in RF-
positive patients, and boys are more likely to be in the younger age group. Chronic uve-
itis develops in approximately 5–10% of these children (Cassidy and Petty 2001; Fink et 
al. 1995), and such cases are frequently ANA-positive.
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3.3 Oligoarthritis, persistent/extended
Oligoarticular onset JIA, involving 1 to 4 joints, is the largest patient category (50–75% 
of patients). Most patients are girls and the peak incidence is at the age of 3 years. Th ese 
young children are frequently ANA-positive and chronic uveitis is common (10–20%) 
(Kotaniemi et al. 2003). Th e fi rst aff ected joint is most typically the knee. Th ere are 
two subgroups of oligoarthritis: persistent and extended, in which latter the arthritis 
spreads to more than 4 joints aft er the fi rst 6 months of disease. Patients with extended 
oligo arthritis have an outcome comparable to those with initial polyarthritis. In those 
with persistent oligoarthritis the articular prognosis is oft en good; remission frequently 
occurs in 4 or 5 years (Woo and Wedderburn 1998). No outcome diff erence has been 
shown between patients with persistent monoarthritis and those with oligoarthritis 
(Stillman and Barry 1977).
3.4 Enthesitis-related arthritis
Patients with enthesitis-related arthritis are oft en boys of the age of six or older. Th ey 
typically have asymmetrical arthritis of the lower limbs and enthesitis, the latter being 
an infl ammation of the attachment between the bones and tendons. Th ere is a strong 
association with the HLA allele B27 and such patients are at risk of developing acute 
anterior uveitis. Subsequently they may develop a disease resembling chronic spondylo-
arthropathy of adults (Woo and Wedderburn 1998).
3.5 Juvenile psoriatic arthritis
Juvenile psoriatic arthritis is defi ned as a chronic infl ammatory arthritis occurring be-
fore the age of 16 years, preceded by, accompanied by, or followed by psoriasis. Th e 
diagnosis of psoriatic arthritis is based either on arthritis associated with a typical psori-
atic rash, or arthritis associated with at least two of the following three minor criteria: 
nail abnormalities, dactylitis and a positive family history of psoriasis in a fi rst-degree 
relative.
Patients with psoriasis may have diff erent types of articular involvements. A large 
majority of these children have an asymmetric oligoarthritis aff ecting small as well as 
large joints at disease onset, although with time most of them become polyarticular. 
Patients are usually RF-negative, but some with psoriasis may have RF-positive poly-
arthritis resembling adult RA (the presence of RF is regarded as an exclusion criterion 
for psoriatic arthritis) (Petty et al. 1998). A few HLA B27-positive patients will develop 
ankylosing spondylitis with sacroilitis. Juvenile psoriatic arthritis is quite rare and there 
is a slight predominance of girls (Southwood et al. 1989).
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3.6 Distribution of subtypes of juvenile idiopathic arthritis
Studies of the occurrence of JIA have revealed some ethnic variation in the propor-
tion of disease subtypes. In populations of North European ancestry oligoarthritis is 
the most common type of JIA, comprising 50 to 75% of cases. Th e proportion of poly-
arthritis is estimated to be 20% to 40% of JIA cases and the great majority of these are 
RF-negative. Systemic onset JIA is diagnosed in about 3 to 10% of JIA patients. Accord-
ing to the Durban classifi  cation the proportion of enthesitis-related arthritis is about 7% 
to 10% and that of psoriatic arthritis about 4% to 5% (Cassidy and Petty 2001).
In line with the previous comment, in community-based studies from Finland, 
66–76% of children have had oligoarthritis, 18–31% had polyarthritis, and only 3–6% 
systemic onset JIA (subclassifi cation according to ARA criteria) (Lantto and von Wendt 
1985; Kunnamo et al. 1986; Kaipiainen-Seppanen and Savolainen 1996). 
Th e proportion of polyarticular JIA appears to be high and that of pauciarticular 
JIA strikingly low among African, East Indian, Japanese, and Th ai children (Grahan 
and Glass 1997). Th is may be due in part to selective loss of mild oligoarthritis cases 
from the patient series. On the other hand, there is probably a true dearth of early-onset 
pauciarticular disease in non-Caucasian patients (Oen and Cheang 1996). A high fre-
quency of seronegative spondyloarthropathies was reported among Inuit children in 
the Northwest territories of Canada (Oen et al. 1986). No diff erences have been noted 
between racial groups in the proportion of patients with systemic onset JIA.
3.7 Complications of juvenile idiopathic arthritis
Ocular complications are common in children with JIA and visual impairment may be 
a consequence of chronic silent uveitis. Two types of uveitis are linked to JIA. Chronic 
uveitis is usually asymptomatic and oft en bilateral. It is most commonly seen in ANA-
positive girls with early-onset oligoarthritis. Th e same type of uveitis occurs less fre-
quently in polyarticular disease and very rarely in the systemic form of JIA. In most 
instances, uveitis manifests within 7 years from the onset of arthritis, but may in fact 
precede arthritis by years (Kanski 1990). Th e other type of uveitis, acute anterior uveitis, 
is more acute and clearly symptomatic. Patients are generally preteen and teenage boys 
and they are usually ANA-negative. Acute anterior uveitis is oft en associated with en-
thesitis-related arthritis (Woo and Wedderburn 1998).
Abnormalities of growth and development sometimes complicate severe JIA. Both 
the chronic infl ammatory state and anti-infl ammatory treatment with glucocorticoster-
oids may impede linear growth. Infl ammation of joints can result in local growth dis-
turbances, causing micrognathia, bradydactyly and unequal length of long bones. Long 
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duration of active disease can lead to shortening of muscles and tendons, which may 
give rise to fl exion contractures. Some serious extra-articular manifestations associated 
mainly with systemic onset JIA are heart involvements such as pericarditis, myocarditis 
and endocarditis, severe anemia or, more rarely, disseminated intravascular coagulation 
(Schwartz et al. 1992). 
Secondary amyloidosis is one of the most serious long-term complications of JIA. 
According to some studies the majority of amyloidosis patients have the systemic dis-
ease subtype (Stoeber 1981). Th e incidence of secondary amyloidosis as a complication 
of JIA has been reported to be rare in North America, but is found more commonly in 
European children with JIA. Th ere is evidence that the incidence of amyloidosis in JIA 
is declining (Savolainen and Isomäki 1993). 
3.8 Autoantibodies in juvenile idiopathic arthritis
Many immunological abnormalities, including the production of autoantibodies, have 
been observed in children with various forms of chronic arthritis, but few fi ndings are 
clinically useful or well understood (Leak 1988; Lawrence et al. 1993). Th e most com-
mon immunological abnormality in JIA is a positive ANA, which usually ex hibits a 
homo geneous or speckled pattern in the indicator cell. Th e frequency of positive re-
action depends on the techniques applied. On average, ANA has been detected by 
immuno fl uorescence in roughly 30% of children with JIA, most frequently in patients 
with oligoarthritis, less so in those with RF-negative polyarthritis and only seldom in 
the other subtypes of JIA. ANA-positive JIA patients run a greatly increased risk of de-
veloping uveitis. Th e underlying reason for this association is not known.
Specifi c components of nuclei have been identifi ed as the antigens for the ANA re-
action in patients with systemic lupus erythematosus and certain other systemic rheum-
atic diseases such as double-stranded DNA, Sjögren syndroma antigens (SS-A, SS-B) 
and Sm (Smith) antibodies. Antibodies against these components do not occur in pa-
tients with JIA; the nature of the antigen(s) responsible for positive ANA in JIA patients 
has not yet been settled with certainty.
Antibodies against soluble bovine retinal S protein may be linked to ocular dam-
age in patients with JIA, since children with JIA-associated uveitis have been reported 
to have higher antibody levels compared to those without eye disease and to normal 
controls (Petty et al. 1987). Other investigators, however, have not been able to confi rm 
this fi nding (Edelsten et al. 1996). Type II collagen induces arthritis, and occasionally 
uveitis in animals. In children with arthritis and uveitis, antibodies and cell-mediated 
immunity to native or denaturated human or bovine collagen are not more frequent 
than in children with arthritis alone (Petty and Hunt 1989). 
RF as determined by conventional test techniques occurs only seldom in patients 
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with JIA. Th ose children who do have a persistent high-titred RF quite obviously have 
a genuine RA which has its onset in childhood. Some attention has been paid to the 
occurrence of so-called hidden RF, i.e. RF blocked by autologous IgG, in other forms 
of JIA (Lawrence et al. 1993), but there seems to be no unanimity as to the validity of 
these fi ndings.
4 Genetic epidemiology of juvenile idiopathic arthritis
Th ree lines of evidence support the conception of a role of genetic predisposition to JIA: 
racial diff erences in risk and the predominance of diff erent JIA subtypes in diff erent eth-
nic groups, the occurrence of multiple cases of JIA in families, and associations between 
particular HLA alleles and certain forms of JIA.
4.1 Familial aggregation of juvenile idiopathic arthritis
Th e starting-point in determining the genetic component involved in the etiology of 
the disease is to observe the clustering of disease in certain families. However, familial 
clustering can be caused by genetic factors, shared environment, or both. Reports of 
families with multiple aff ected members are rare in JIA.
Ansell and associates (1969) made detailed family studies examining clinical, sero-
logical and radiological variables among 228 fi rst-degree relatives of 92 probands meet-
ing the criteria for a JCA-resembling disease, and found some excess of infl ammatory 
rheumatic diseases compared to the adult population as a whole. Most of the cases 
among relatives were of adult onset; no data were given on diseases already commenc-
ing in childhood. In a study from the Netherlands a higher than expected prevalence 
of spondyloarthropathy (4% vs 0.25%) was noted among parents of 70 children with 
oligoarticular arthritis (Hertzberger-ten and Dijkmans 1993). In a Swedish population-
based cohort study 5.6% of patients with JIA had mothers who had been diagnosed with 
RA. Of these patients 9.7% had a fi rst-degree relative with psoriasis and 2.4% a father 
with AS (Andersson Gäre and Fasth 1995). Prahalad and colleagues (2002) demon-
strated that relatives of patients with JIA evinced an increased frequency of auto immune 
disorders (12.6% vs 4.0% in control individuals) and that the prevalence of infl amma-
tory arthritis was higher among relatives of JIA-aff ected sibpairs (ASP) than in simplex 
families. No details were given concerning the type of arthritis.
Typical for diseases with a genetic predisposition is that fi rst-degree relatives of an 
aff ected individual are at increased risk of disease (Risch 1990). Th e most commonly 
used indicator of the magnitude of the genetic component is the sibling recurrence ratio 
(λs), i.e. the prevalence of the disease in sibs of aff ected probands divided by the preva-
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lence of the disease in the general population (Glass and Giannini 1999). Th e familial 
aggregation of JIA was recently demonstrated by identifying multiplex JIA pedigrees in 
a study by Prahalad and associates (2004), who provided a population-based estimate of 
the recurrence risk for fi rst-degree relatives of about ~ 30.
4.2 Affected sibling pairs with juvenile idiopathic arthritis
Other reports of families with multiple aff ected members involve aff ected sibpairs. Yod-
fat and colleagues (1971) described a family in which fi ve out of seven siblings had 
JIA with an oligoarticular course. Th e fi ft h had an initial history of arthralgia but it 
remained unclear whether true arthritis was ever documented. Rosenberg and Petty 
(1980) reported two ASPs in whom the clinical course was concordant in both members 
of the pair. One pair with pauciarticular JIA were also concordant for the presence of 
chronic uveitis. Ansell and Albert (1984) published data on 19 families with ASPs col-
lected in Taplow and Northwick Park, England.
Two small sibling series and a larger one with more detailed data on HLA haplotype 
sharing have been published. Clemens and associates (1985) reported data on 12 fami-
lies with sibling pairs aff ected by RF-negative JIA. Th e ASPs were gathered from among 
patients admitted to Juvenile Rheumatism Units at Taplow, England and Garmish-
Partenkirchen, Germany. Th e study focused on HLA haplotype sharing and provided 
rather little clinical information on the patients. Perhaps the most striking clinical fi nd-
ing was that 11 pairs were concordant for the onset type. Likewise, in 11 pairs the dis-
ease began at about the same age. Suciu-Foca and associates (1980) evaluated 14 ASPs 
with pauciarticular JIA, but mainly from a genetic (HLA) point of view.
An ASP series from the United States was collected by means of a multiple advertis-
ing campaign directed to United States physicians likely to care for patients with JIA. 
Moroldo and associates (1997) reported 71 ASPs. A higher than expected degree of con-
cordance for onset type suggested a role of genetic infl uences. Prahalad and colleagues 
(2000/a) continued the study and described altogether 118 pairs of siblings registered 
in the above National Institute of Arthritis and Musculoskeletal and Skin Diseases–
sponsored Research Registry for JRA ASPs. Recently, complete clinical information has 
become available on 183 ASPs (Moroldo et al. 2004).
Th e prevalence fi gure for JIA in the general population is based on fairly reliable 
data, but that for JIA in sibs of those aff ected is only an estimate, since there are no 
satisfactory data on the population from which the ASP series were derived. In a study 
described by Clemens and colleagues (1985) six of the 12 ASPs were reported to be 
derived from 2 000 patients in a clinic population. On the basis of the above fi gures it is 
diffi  cult to compute the risk to siblings of aff ected family members. Glass and Giannini 
(1999) suggested a λs of 15 from fi gures for the estimated total number of 300 JIA ASPs 
in the US population, in which there are about 71 000 patients with JIA.
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4.3 Twin pairs with juvenile idiopathic arthritis
A classic twin study compares concordance of monozygotic (MZ) and dizygotic (DZ) 
twins for disease, higher concordance rates observed in MZ than in DZ twins provid-
ing evidence for the involvement of genetic factors in the disease. However, the MZ/DZ 
ratio is dependent on the number of genes involved, not only on the magnitude of the 
genetic component. Likewise, in diseases of multifactorial etiology the twin concord-
ance rate is largely a measure of disease prevalence (Järvinen and Aho 1994).
Comparison of MZ and DZ twins, assuming that they share disease-relevant en-
vironmental factors to a similar degree but diff er in their genetic similarity, allows as-
sessment of heritability, which estimates the extent to which variation in the liability 
to disease in a population can be explained by genetic variations. It is independent of 
disease prevalence, and tells of prevailing individual genetic diff erences.
Baum and Fink (1968) reported an MZ twin pair with identical disease onset and 
course; both patients were diagnosed as having pauciarticular JIA. Kapusta and asso-
ciates (1969) described one pair of identical twin boys and their mother who all had 
JIA. In all three, the disease progressed to chronic deforming polyarthritis, the onset 
of the disease was at an early age and the disease diff ered only in that the sons were 
ANA-positive and the mother ANA-negative. Husby and associates (1988) published 
a report on immunological studies of an MZ twin pair concordant for severe polyar-
ticular JIA but discordant for monoclonal gammopathy and amyloidosis. Ansell, in her 
review of chronic arthritis in childhood, (1978) reported altogether six concordant MZ 
pairs. Two pairs had juvenile AS; no details were given on the phenotype in the other 
pairs. Meyerowitz and colleagues (1968) reported eight sets of MZ twins discordant for 
arthritis. Th ree of these sets had juvenile onset disease, one-RF positive and the other 
two pauciarticular.
From the ASP series reported by Moroldo and colleagues (1997) and by Prahalad 
and colleagues (2000/a) altogether 14 pairs of twins concordant for JIA were reported. 
Eleven pairs were MZ, one pair was opposite-sex DZ, and the zygosity of two pairs is yet 
to be determined (Prahalad et al. 2000/b). Th e most recent clinical information includes 
19 pairs of twins (Moroldo et al. 2004). No conclusions were drawn as to the frequency 
of JIA among MZ or DZ twins, since the information was derived from a registry to 
which ASPs were selectively referred.
To judge from reported twins aff ected by JIA concordance for onset and course type 
has been fairly high in MZ twins. In addition, the onset of disease in twins has been re-
ported to be much closer chronologically compared with that in non-twin ASPs. How-
ever, it is likely that MZ twin pairs concordant for a number of features are reported 
more frequently than pairs discordant for these features. To avoid selection bias, pa-
tients should ideally be identifi ed from a population-based source.
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5 Associations with genetic markers
5.1 The whole-genome scan
Genome-wide screening, in which all chromosomes are systematically screened in 
search of novel suscebtibility loci, can be used as an initial step in identifying genes 
predisposing to disease. Th e markers traditionally used are short tandem repeats, e.g. 
microsatellites, where DNA sequences show considerable variation among individu-
als (polymorphism). Recently, single nucleotide polymorphisms (SNP), single base pair 
variations, have been increasingly used for more detailed genotyping in chromosomal 
regions where a potential linkage may exist. 
Data have been published from the fi rst genome-wide screen in JIA populations, 
carried out in 121 pedigrees involving 130 JRA-aff ected sibpairs from the National Insti-
tute of Arthritis and Musculoskeletal and Skin Diseases sibpair registry (Th ompson et 
al. 2004). Six chromosomal regions showed some evidence of linkage with JIA, loga-
rithm of odds (LOD) score > 1 (p-value = 0.014), the most promising at chromosome 6. 
However, the thresholds for signifi cant linkage (LOD > 3.3) and for suggestive linkage 
(LOD > 1.9) were not reached (Lander and Kruglyak 1995).
5.2 Candidate gene approach 
A chromosomal region, once having indicated an area of interest for further analyses, 
can be used in the evaluation of candidate loci. Several aspects may be considered when 
selecting genes for investigation in JIA. Th e nature of the histopathology of the infl amed 
synovium is one starting-point. Th ere is thus evidence that the underlying driving force 
for the chronic synovitis of JIA is antigen-driven and T-cell-mediated. Another impor-
tant starting-point for genetic investigation is the expression of infl ammation-associ-
ated proteins in aff ected children (Th omson and Donn 2002). However, there is hardly 
anything specifi c for JIA; the same arguments can be used for selecting candidate genes 
for most infl ammatory joint diseases.
HLA genes probably account only for a certain part of total susceptibility, leaving 
the rest still to be identifi ed. Non-HLA gene associations with JIA have recently been 
reviewed by Forre and Smerdel (2002), Th omson and Donn (2002/b) and Rosen and 
colleagues (2003). With one exception, the work done so far comprises only candidate 
gene studies, being therefore limited in respect of an overall assessment of genetic sus-
ceptibility to JIA. Of the non-HLA genes, attention has been drawn to T cell receptor 
genes, genes encoding diff erent cytokines, natural resistant-associated macrophage pro-
tein 1 gene (regulating the expression of chemokine/cytokine genes), interferon regula-
tory factor and macrophage migration inhibitory factor. Taken as a whole, only few of 
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the observations have been confi rmed, the odds ratios in most instances have been low 
and inconclusive, and many initially promising fi ndings of candidate genes have suf-
fered from lack of replication.
5.3 Analytical methods
Th e methods available for genetic investigation of complex traits are linkage analysis, 
which uses one of two basic techniques: lod score methods or allele-sharing methods, 
and association studies.
5.3.1 Linkage analysis
Linkage studies are designed to map previously unknown genes of etiologic relevance. 
Parametric linkage analysis follows co-segregation of two genetic factors at specifi c loci 
in pedigrees, using the frequency of meiotic recombination as an estimate of genetic dis-
tance. Th e establishment of linkage through conventional linkage analyses (logarithm of 
odds score) has been diffi  cult in JIA due to lack of families with multiple cases aff ected. 
Th ese linkage studies are likely to require several hundreds, possibly even thousands, 
of aff ected sibling pairs to provide suffi  cient power to detect linkage (Risch and Meri-
kangas 1996).
One means of measuring linkage in complex diseases where the mode of inherit-
ance is unknown is to use non-parametric linkage analysis. Allele-sharing methods and 
the simplest form of this method, aff ected sibling pair analysis, is a test for an excess of 
disease-associated allele-sharing in ASPs (Risch 1990). Th e method does not depend on 
the existence of linkage disequilibrium between the markers being tested and the disease 
genes, since the analysis is performed within families. Th e method can be divided into 
modifi cations which depend on marker alleles shared identical-by-descent and those 
which rely on alleles shared identical-by-state. Two alleles are said to be identical-by-
state if they are the same variant of some polymorphic system, whereas identical-by-de-
scent depends in addition on whether these alleles are inherited from a common ances-
tor. Each ASP is expected to share identical-by-descent 0, 1 and 2 alleles with respective 
probablities of 0.25, 0.5 and 0.25 according to random Mendelian segregation. When 
the parental genotypes are unknown, the probabilities of sibs sharing alleles identical-
by-descent can be estimated depending on the frequency of the observed alleles at the 
marker locus in question (Lange 1986).
Two small sibling series have been published detailing haplotype sharing (Suciu-
Foca et al. 1980; Clemens et al. 1985) and a larger one on allele sharing (Prahalad et al. 
2000/a) in JIA patients. A marked excess of shared haplotypes was recorded in the very 
small series reviewed by Clemens and associates (1985) (p = 0.006). Prahalad and col-
leagues (2000/a) focused on the DR locus, as this is believed to be the major HLA locus 
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determining susceptibility to JIA. Based on statistics designed for identity-by-state, the 
authors showed a signifi cant excess of sharing 0, 1 or 2 DR alleles: 8 : 40 : 32, instead of 
the expected ratio of 20 : 40 : 20 (p < 0.001).
5.3.2 Association-based methods
Association studies are non-parametric tests which have been used to determine whether 
marker allele frequencies at a given locus diff er between aff ected and unaff ected indi-
viduals. An allele is said to be associated with a trait if it occurs at a signifi cantly higher 
frequency among aff ected compared with control individuals. Association studies are 
either case-control or family-based. In case-control studies the frequencies of genetic 
markers in patients are compared with those in control populations. Nearly 100 stud-
ies comprising diff erent population groups have shown some consistent associations of 
HLA loci with specifi c subtypes of disease (for details see section 5.4.)
In family-based association studies the aff ected proband and members of the family 
are typed and assessed for evidence of disease. Th e tests require the presence of both 
association and linkage between the locus tested and the disease gene. Genetic linkage 
is assumed when two gene loci are physically close together on the chromosome. A dis-
ease gene will be linked to a particular allele within a given aff ected family but will not 
necessarily be associated with the same allele in unrelated aff ected persons.
Th e most popular extension of this approach is the transmission disequilibrium test 
(TDT), which focuses solely on heterozygous parental genotypes. TDT determines how 
many times potential disease alleles are transmitted from heterozygous parents to af-
fected off spring and compares this number to the number of times transmission does 
not occur (Spielman and Ewens 1996). Th is method is an oversimplifi cation for a situa-
tion where the aff ection status among other relatives is completely ignored.
In an American study by Moroldo and associates (1998) the TDT results established 
family-based associations of HLA alleles with pauciarticular onset JRA (HLA-A2, B27, 
B35, DR5 and DR8). Two other marker association studies have been conducted examin-
ing multiple markers in the major histocompatibility complex (MHC) region in addi-
tion to specifi c HLA genes (Zeggini et al. 2002; Runstadler et al. 2003).
5.4 Associations with HLA alleles
5.4.1 HLA system
Until recently, most of the genetic work on JIA has centred on HLA genes within the 
MHC located on the short arm of chromosome 6 (6p21.3). Th is is the most polymorphic 
system known in the human genome, consisting of several closely linked loci. Many of 
the genes within the MHC complex are associated with immune functions, and associa-
30
tions of specifi c HLA polymorphisms with several rheumatic diseases have been recog-
nized (Nepom and Nepom 2003; Klein and Sato 2000). 
Th e HLA region has been divided into three diff erent subregions, class I, class II 
and class III (Figure 1). Class I antigens: HLA A, B and C consist of a polymorphic 
α chain encoded by HLA genes, and a β chain, in which beta-2 microglobulin is coded 
by a gene on chromosome 15. Class II genes (three major loci: HLA DR, HLA DQ and 
HLA DP) are heterodimeric glycoproteins. Most of the class II antigens consist of two 
diff erent polypeptide chains, α and β, both controlled by genes in the HLA region. Th e 
role of these HLA molecules includes presenting foreign and self antigens to T-cells. 
T cell interacts with T cell receptor (TCR), CD4 and CD8 coreceptors to HLA molecules 
(Figure 2).
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Figure 1 Location and organization of the MHC complex on chromosome 6 (the fi gure is 
modifi ed from Klein and Sato 2000). Th e complex is conventionally divided into three regions: 
I, II and III. Each region contains numerous loci (genes), only some of which are shown. Of 
the class I and II genes, only the expressed genes are depicted. Class III genes are not related to 
class I and class II genes structurally or functionally.
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HLA class I antigens are expressed in most nucleated cells and present cytosolic 
proteins (both self and non-self e.g., viral polypeptides, genetic origin) to CD8+ ‘cyto-
toxic’ lymphocytes. HLA class II antigens are expressed only in antigen-presenting cells 
(activated macrophages, B-lymphocytes, dendritic cells and thymic epithelial cells) 
and present degraded exogenous antigen fragments to CD4+ ‘helper-inducer’ lympho-
cytes.
Th e class III genes are situated between the class I and II genes. Th ey encode for 
instance the complement factors C2 and C4 of the classical complement pathway and 
the properdin factor of the alternative complement pathway, the tumor necrosis factors 
(TNF) alpha and beta, the heat shock proteins and the enzyme 21-hydroxylase. In ad-
dition, genes for large multifunctional proteases involved in antigen processing in the 
cytosol (LMP2 and LMP7) and genes for transporters of antigen peptides (TAP1 and 
TAP2) have been mapped within the HLA region.
5.4.2 Difficulties in determining significant HLA associations
Progress in characterizing the genetic components of JIA and interpreting the signifi -
cance of its HLA associations has proved diffi  cult, for several diff erent reasons. First, 
JIA is not a single disease but a group of clinical syndromes and HLA associations may 
vary between the disease subtypes. Secondly, HLA associations may appear diff erently 
HLA CLASS I
CD8+ lymphocyte
TCR
AG
α β2-m
Most nucleated cells
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Figure 2 Interaction between HLA and T-cell receptor. AG = antigen; TCR = T cell 
receptor; β2-m = β2-microglobulin
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depending on age at onset of the disease. Murray and colleagues (1999) have shown 
HLA-specifi c windows of susceptibility which are, at least in part, related to JIA sub-
groups. Th irdly, irrespective of JIA the frequency of HLA alleles varies widely among 
diff erent ethnic groups, being in fact one of the best anthropologic markers. Diff erences 
in HLA typing methodologies have resulted in diffi  culties in comparing allele frequen-
cies. Th ere are, moreover, diff erences in the occurrence of diff erent subtypes of the dis-
ease among populations. 
Finally, the strong linkage disequilibrium within the HLA region will render it dif-
fi cult to identify the actual predisposing genes. Th e term linkage disequilibrium means 
that certain alleles at neighbouring loci occur together more frequently than expected 
by chance (Jorde 1995). In principle, the HLA region on chromosome 6 is inherited 
en bloc, suggesting that these genes have strong linkage disequilibrium and that jointly 
they have a certain biological meaning.
5.4.3 HLA-gene associations in juvenile idiopathic arthritis
HLA B27 was the fi rst HLA allele found to be associated with JIA, reported in 1974 
(Rachelefsky et al. 1974). Since 1979/80 other HLA associations with JIA as distinct from 
adult RA have been reported (Glass et al. 1980; Stastny and Fink, 1979). Sub sequently, a 
replete of nearly 100 studies involving diff erent population groups have dealt with HLA 
associations of JIA. Most have shown virtually the same allelic associations within the 
same subtype and marked diff erences among the subtypes (Scholz et al. 1993; Donn and 
Ollier, 1996; Glass and Giannini, 1999; Th omson and Silman, 2001; Forre and Smerdel, 
2002). From Finland there is only one earlier study from 1978 (Mäkelä and Tiilikainen, 
1978) covering the HLA A and B loci with a limited number of alleles known at that 
time. 
Th e HLA B27 allele, which is strongly related to ankylosing spondylitis (Brewerton et 
al. 1973; Schlosstein et al., 1973), also contributes to the risk of late onset pauci articular 
disease with a strong male predominance (Rachelefsky et al. 1974). Patients typically 
meet the current criteria for enthesitis-related arthritis. Th e prevalence of HLA B27 is 
also marginally increased in some other subtypes of JIA and may be associated with 
poor prognosis. In a Finnish study by Savolainen and associates. (1998) HLA-B27-posi-
tive cases were clearly accummulated among the most severe cases, i.e. among patients 
needing treatment with cytostatics and patients with amyloidosis or arthroplasty. 
An increased frequency of the HLA A2 (HLA A*0201) allele has been demonstrated 
in children with JIA, particularly in girls with pauciarticular arthritis of early onset (Oen 
et al. 1982). Few studies have dealt with Cw locus alleles. Th ere is some evidence that the 
prevalence of Cw4 is increased in pauciarticular disease (Howard et al. 1985). 
RF-positive polyarthritis in children represents the counterpart of RF-positive RA 
in adults. Th e HLA associations are the same in these two patient groups; in particular, 
certain subtypes of HLA DR4 are involved (Vehe et al. 1990). 
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Early onset oligoarthritis occurs predominantly in girls and is not infrequently (in 
about 20% of cases) complicated by chronic iridocyclitis. In addition to HLA A2, a 
number of HLA class II alleles have been associated with this subtype (DRB1*08, DR5 
(DRB1*11 and DR12), DR6 (DRB1*1301) as well as DQA1 *0401, *0501, *0601 and 
fi nally DP2 (DPB1*0201) (Albert and Scholz 1998; Nepom and Glass 1992; Paul et al. 
1995). According to some studies HLA allele DRB1*1104 (a split of HLA DR5) is associ-
ated with the occurrence of chronic iridocyclitis (Malagon et al. 1992; Melin-Aldana et 
al. 1992). Recently, some evidence has been presented that persistent oligoarthritis and 
extended oligoarthritis are immunogenetically distinct (Zeggini et al 2002). Th omson 
and colleagues (2002) demonstrated a possible increase in the frequency of one haplo-
type (DRB1*13-DQA1*01-DQB1*06) in persistent oligoarthritis. 
Th e HLA DRB1*0801 allele has the strongest association with RF-negative JIA, in 
both oligoarthritis and polyarthritis. Th e HLA DR8/DQ4 haplotype has been reported 
to represent a marker of seronegative arthritis in children in many populations (Nepom 
et al. 1992; Smerdel et al. 2002/b). Th e relative importance of the closely linked DR and 
DQ loci is diffi  cult to establish. 
In contrast to HLA DR/DQ alleles, reported disease associations with the DP locus 
are few. A number of studies have shown an association between oligoarthritis and HLA 
DPB1*0201 (Albert and Scholz 1998). RF-negative polyarthritis has been reported to be 
associated with HLA DPB1*0301 (Fernandez-Vina et al. 1990; Barron et al. 1992). Th is 
allele has been suggested to be associated with some subsets of RF-negative RA of adults 
(Gao et al. 1991). 
Th e HLA associations in systemic JIA appear to be relatively weak and inconsistent. 
Some studies have shown an increase in DR4 (especially with severe arthritis in children 
with systemic onset JIA), although the association appears to be limited to Northern 
European populations (Miller et al. 1985; Nepom and Glass 1992; Paul et al. 1995), and 
may be a refl ection of a higher frequency of DR4 in northern Europe.
Linkage disequilibrium across diff erent HLA regions is strong. However, Zeggini 
and colleagues (2002) showed that at least the loci HLA-A and HLA DRB1 contribute 
independently to oligoarhritis and that these associations seem not to be a result of 
linkage disequilibrium between the markers involved, suggesting that in some patients 
several diff erent HLA alleles (i.e. several HLA genes) are involved in the pathogenesis 
of JIA (Forre and Smerdel 2002). Th e available information on HLA associations is 
summar ized in Table 3 (modifi ed from Forre and Smerdel 2002).
In addition to the much studied HLA class II loci, the MHC contains many other 
genes which could be directly involved in JIA risk, or might interact with HLA II alleles. 
Of these, special emphasis has been laid on TNF protein and its receptors. Th e TNF re-
gion is highly polymorphic. Many of the alleles in question are in linkage dis equilibrium 
with DR/DQ alleles, rendering it diffi  cult to assess the independent role of genes in this 
region. 
Recently, a positive association was described for a marker by the micro satellite 
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D6S265 located in the vicinity of HLA-A, (Smerdel et al. 2002/a). Th is novel sus cepti-
bility gene in linkage disequilibrium with D6S265 will infl uence the risk of JIA in-
dependently of the DR-DQ haplotype. Th is provides additional evidence for the JIA 
susceptibility genes in the HLA class I region.
Due to a higher than expected prevalence of certain HLA alleles, other alleles may 
be compensatorily decreased. Claims that there may be alleles which seem to be truly 
protective are thus not easily confi rmed.
Table 3 HLA association with juvenile idiopathic arthritis.
JIA subgroups HLA genes 
Oligoarticular Class I: A*0201, Cw4?, B27?
 Class II: DRB1*08, DR5 (DRB1*11, DRB1*12), 
  DR6 (DRB1*1301)
  DQA1*0401, DQA1*0501, DQA1*0601
  DPB1*0201
Polyarticular RF-negative JIA Class II: DRB1*0801, DQB1*0402
  DPB1*0301?
Polyarticular RF-positive JIA Class II: DRB1*04
Systemic JIA Class II: DRB1*04
Enthesitis-related arthritis Class I: B27
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Aims of this study
Th is study was undertaken to investigate in the genetically homogeneous Finnish popu-
lation the genetic factors predisposing to JIA and to determine the clinical character-
istics of the disease in families with multiple cases derived from a defi ned basic JIA 
population. Special emphasis was laid on HLA alleles and haplotypes.
Th e specifi c aims were:
1 To obtain information on the magnitude of the genetic component in JIA.
2 To compare the disease type in familial and sporadic JIA patients to obtain informa-
tion on whether these represent basically the same disease.
3 To obtain information on the occurrence and characteristics of uveitis in sibling 
pairs aff ected with JIA.
4 To study the prevalence of chronic infl ammatory rheumatic diseases among parents 
who have two or more off spring aff ected by JIA.
5 To determine the eff ects of class I (A, C, and B) and II (DRB1 and DQB1) HLA loci 
alleles on genetic susceptibility to JIA in families with two or more aff ected siblings.
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Patients and methods
1 Patients and families
Multicase JIA families have been traced systematically at the Rheumatism Foundation 
Hospital in Heinola over a period of about 15 years. Th e hospital is a semi-private insti-
tution which receives patients from university and other central hospitals and directly 
from primary care, especially if the patient lives in an area near the hospital. It provides 
in- and outpatient care in conservative rheumatology, orthopedics and rehabilitation 
for children and adults. According to the patient register it has been estimated that 
about two-thirds of all Finnish JIA patients are seen at the Rheumatism Foundation 
Hospital, some regularly and others only occasionally.
1.1 Number of affected sibling pair families
During the period 1985 to 2000 41 families with 88 siblings aff ected by JIA satisfying 
the Durban criteria for JIA were found among the 2 312 patients treated at the pedi-
atric department of the Rheumatism Foundation Hospital. Of these, about 90% had 
JIA. It can thus be estimated that the population of JIA cases from which the multicase 
families were derived amounted to some 2000 patients. Th is corresponds to about 60% 
of JIA cases in the country as estimated on the basis of the incidence of JIA in Finland 
(Kaipiainen-Seppänen and Savolainen 1996). In addition, four new families were later 
ascertained (study V).
Th e number of ASPs varied to some degree in diff erent studies; the precise fi gures 
are shown in Table 4. Families having three aff ected siblings were counted as having 
three ASPs. No family had more than three aff ected siblings.
Of the 41 identifi ed ASP families, HLA genotyping was undertaken in 38 nuclear 
families (study VI), as one family refused DNA analysis and one sibling pair was ex-
cluded due to technical reasons. One family was excluded because the pair was an MZ 
twin pair. Th e genetic analysis of an MZ twin pair cannot be regarded as a full sibling 
case, since identical twins would be expected to share all of their genetic information. 
1.2 Diagnostic issues
All JIA patients and their parents were asked for a family history of rheumatic diseases. 
Th ose providing a positive answer fi lled a questionnaire requesting more details of the 
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medical history of rheumatic diseases in the family. Th e diagnoses were confi rmed from 
patient records.
Information on the parents’ chronic infl ammatory rheumatic diseases in multiple 
JIA families were collected from the parents themselves and the diagnoses were checked 
from the hospital records; the parents were not clinically studied. A total of nine parents 
from eight families were found to have some chronic rheumatic disease entitling to 
medication specially reimbursed by the National Social Insurance Institution. Eligi bility 
for such approval in Finland requires a comprehensive medical certifi cate written by 
the attending specialist physician and approved by an expert adviser on behalf of the 
sickness insurance scheme. Th e certifi cates are not keyed to any specifi c criteria but are 
written to provide evidence that a subject has a chronic rheumatic disease and needs 
drug treatment for it (Myllykangas-Luosujärvi et al. 1995).
On the basis of information collected the diagnoses in children with chronic in-
fl amma tory joint disease were classifi ed using the Durban criteria for JIA (Petty et al. 
1998). Th e diagnoses of RA in parents were classifi ed using the ACR classifi cation cri-
teria (Arnett et al. 1988) and for the diagnosis of spondyloarthropathy the preliminary 
criteria of the European Spondylarthropathy Study Group were used (Dougados et al. 
1991). 
In patients with JIA, the relevant clinical data and laboratory test results (ANA, RF) 
were recorded during the fi rst six months from diagnosis (onset type) and during the 
subsequent follow-up (course type). Th e characteristics of the disease were evaluated 
during the follow-up. 
1.3 Clinical findings in affected sibling pairs
Th e 50 ASPs in Study VI were derived from 83 patients, comprising 31 aff ected ASPs and 
seven sets of triples (three aff ected siblings in a family) with JIA (62 + 21 patients). As 
Table 4 Number of families, patients and ASPs available in diff erent studies.
 Study
 II III, IV VI
No. of families 41 37 38
No. of patients 88 80 83
 boys  34  31  31
 girls  54  49  52
No. of ASPs  52 49 50
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noted above, the genetic analysis of an MZ twin pair cannot be regarded as full-sibling, 
as identical twins would be expected to share all of their genetic information. Th us a 
triple set including MZ twins was considered as one sibling pair. Each other triple set 
was counted as three sibling pairs; the series thus comprised a total of 50 ASPs (32 + 18 
ASPs). Of the aff ected index cases, 31 were boys and 52 girls. Th e diff erence in distribu-
tion of diagnosis between boys and girls was not statistically signifi cant (p = 0.32). Of 
the 50 ASPs, 8 were boy–boy, 17 girl–girl and 25 boy–girl pairs. Of the six trios, four 
were boy–boy–girl and two boy–girl–girl.
Th e onset type was oligoarticular in 55 patients (66%). Th e disease progressed into 
extended oligoarthritis in 16% of the patients. Th e disease was persistent oligoarticular 
in 42 (51%) of the patients and in most instances ran a mild course. Th e distribution of 
the subtypes is depicted in greater detail in Table 5.
Table 5 Disease subtypes among the 83 patients classifi ed according to the Durban criteria.
Disease subtypes Boys (N = 31) Girls (N = 52) ALL
 N (%) N (%) N = 83
Systemic 1 (3) 2 (4) 3 (4)
Oligo:
 persistent 17 (55) 25 (48) 42 (51)
 extended 3 (10) 10 (19) 13 (16)
Poly
 RF+ 0 (0) 1 (2) 1 (1)
 RF− 7 (23) 14 (27) 21 (25)
Enthesitis-related     2 (6) 0 (0) 2 (2)
Psoriatic 1 (3) 0 (0) 1 (1)
Th e mean age at diagnosis of JIA was 4.5 years, range 1.0–15.7 years, median 3.2 
years. In girls the mean age was 4.2 (median 3.0) and in boys 5.1 years (median 4.1).
To detect insidious uveitis in study IV, the patients were examined by an ophthal-
mologist at least once, usually two to four times a year. Th e examination involved de-
tection of best corrected visual acuity, ocular pressure (when possible), biomicroscopy 
and examination of the fundus of the eye. Th e type of uveitis was determined and com-
plications of uveitis were sought. Patients with active uveitis were checked at intervals 
of 1–3 months.
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1.4 Population-based controls (study III and VI)
For the comparison of patients with JIA in the sibling series and in the population-
based series in Finland, those 114 JIA patients in whom the diagnosis had been made in 
1980, 1985 and 1990 in fi ve of the 21 central hospitals districts of Finland (Keski-Suomi, 
Tampere, Päijät-Häme, Kymenlaakso, Kuopio) were used. Hospital records of the pa-
tients in a population-based series published by Kaipiainen-Seppänen and Savolainen 
(1996) were reanalysed to obtain additional information on certain characteristics of 
disease, for example the number of joints involved, and on certain laboratory measures 
at diagnosis.
Data on HLA allele frequencies among Finnish bone marrow donors (14 752 per-
sons) were used to represent frequencies in the Finnish background population, ob-
tained through the courtesy of Dr Jukka Partanen, PhD, from the Finnish Red Cross 
Blood Transfusion Service.
2 DNA extraction and HLA genotyping
Samples from JIA patients and their relatives have been collected from 1997 on. Most 
of the samples were fresh 10 ml whole blood samples delivered in EDTA tubes to the 
National Public Health Institute, Helsinki, where DNA isolations were carried out by 
PUREGENE DNA isolation protocol (Web site: http://www.gentra.com/protocols/
00190.pdf). Th ere were also 6 samples of saliva, for which DNA isolation was carried 
out (DNA isolation protocol for 3 ml saliva, Web site: http://www.gentra.com/protocols/
00882.pdf). 
HLA A, C, B, DRB1 and DQB1 typing was performed in 83 JIA patients, their par-
ents and 45 healthy sibs. Th is family-based approach enabled unambiguous determin-
ation of haplotypes for each sibling. HLA polymerase chain reactions were performed 
according to the appropriate Dynal® Allset+TM SSP (sequence specifi c primers) kit 
proto col (Dynal, Oslo, Norway) and serologic typing or sequence-based typing (SBT) 
by Visible Genetics® GeneKitTM (Visible Genetics, Toronto, Ontario, Canada). 
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3 Statistical methods
3.1 Statistical comparisons between series 
Statistical comparisons between sibling and population series were made using the 
chi-squared test, Fisher‘s exact test (Freeman-Halton), Student‘s t-test and the Mann–
Whitney test. In genetic studies variables observed in individuals in pedigrees are not 
fully independent observations. Statistical comparisons between sibling and population 
series in original publications III, IV and VI were made using the data for all individu-
als, ignoring their relationships. For a summary we computed the fi gures using a single 
individual from each family. Th e single case used was a proband who was the individual 
causing a family to be identifi ed, and in the current study he/she was the fi rst aff ected 
member in the family.
3.2 HLA data on patients versus control cases
Th e frequencies of HLA-A, -C, -B, -DRB1 alleles in the patients with JIA were compared 
with unaff ected controls. Finnish bone marrow donors (14 752 cases) from the Finnish 
Red Cross Blood Transfusion Service were used to represent frequencies in the Finnish 
background population. HLA results on bone marrow donors were available only at 
sero logical level. Odds ratios and their 95% confi dence intervals (CI) were applied to 
compare the HLA allele frequencies. 
3.3 Affected sibling pair analysis method
ASPs are defi ned as full-biologic siblings who both (or all) have JIA. HLA genotyping 
was performed in 38 nuclear families (study VI). Th e series consisted of 32 families 
with an aff ected sibpair and 6 families with an aff ected sibling trio. Each aff ected trio 
was counted as comprising three ASPs (sib1–sib2, sib1–sib3, and sib2–sib3), the total 
number of ASPs being thus 32 + 6 × 3 = 50. However, trio sets are not independent and 
various means to correct the resulting error have been suggested (e.g. Holmans 1998). 
In this study none of these counting methods was used.
3.3.1 Linkage analysis
Th e ASP analysis is based on the mendelian paradigm of random segregation of alleles; 
each sibpair is expected to share identical-by-descent 0, 1 and 2 alleles with respective 
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probabilities of 0.25, 0.5, and 0.25. For deviations of observed allele-sharing frequencies 
from the expected, chi-square tests with 2 degrees of freedom were used.
3.3.2 Association methods
Two association-based methods were used: the independent TDT association and the 
family-based association test. Th e classical TDT test compares the transmission of al-
leles from heterozygous parents to the aff ected off spring with the number of times trans-
mission does not occur. Th e JIA-aff ected sibpairs were treated as independent and the p-
value then adapted using a within-family Monte Carlo permutation z’-score procedure 
with continuity correction (Spielman and Ewens 1998). Th e p-value for the z’-score was 
obtained using standard normal distribution. Multiple comparison corrections to p-
values were made by the Bonferroni method according to the number of alleles at a 
given marker locus.
Family-based association analysis of the JIA and HLA alleles uses diseased vs not 
diseased phenotype. Th e test uses all collected pedigree data and no assumptions of 
independence of familial cases are made in the same way as in the classical TDT. In 
this study family-based association tests using the FBAT program were applied (Laird 
et al. 2000). (http://www.biostat.harvard.edu/~fb at/default.html). Each HLA locus was 
analysed by unvariate analysis (allelic eff ects and overall test) and also joint-allelic main 
eff ects were analysed to assess independent allele eff ects. 
4 Ethics
Th e parents had given written informed consent to their family participation in the 
study. Th e study was approved by the Ethics Committee of the Rheumatism Foundation 
Hospital.
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Results
1 Twins (I, II)
1.1 Concordance rate in monozygotic twins
Over the study period of 15 years, eight sets of MZ twins were found; two twin pairs 
were concordant for JIA. Th ere are about four MZ births per 1 000 in the Finnish popu-
lation. Th us our eight MZ pairs indicated that most, if not all, such pairs had been traced 
among the approximately 2 000 JIA patients. A pairwise concordance rate of 25% for a 
disease with a population prevalence of 1 per 1 000 implies a relative risk of 250 for an 
MZ twin, while the probandwise concordance of 40% (4/10) implies an even higher 
relative risk.
1.2 Disease phenotypes of monozygotic twins
Th e disease subtypes of MZ twin pairs concordant for JIA were further studied. In study I 
a phenotypically diff erent MZ twin pair was described; the onset type was systemic in 
one, pauciarticular in the other. Th e subsequent course was similar in both, polyarticu-
lar. In another MZ twin pair the patients were concordant for the disease phenotypes; 
both had oligoarticular onset and polyarticular course. Th e age diff erence at onset of the 
disease was six months in the fi rst twin pair and only two months in the other pair. 
2 Affected sibpair studies (II, III, IV)
2.1 Sibling recurrence risk
Th e computed sibling recurrence risk in this study is only an estimate, for the following 
reasons. First, the number of aff ected sibs among the 41 probands was 47, which may 
not be the fi nal fi gure, because an unaff ected family member may carry susceptibility 
genes to JIA and a proportion of healthy sibs may later develop disease. Second, our 
41 multicase families were found in the basic population of 2 000 patients with JIA. 
Among these families, the exact number of healthy sibs was not known; an estimate was 
obtained from the average number of children, 1.8, in Finnish families; 45% of families 
have only one child, 38% have two children, 13% have three children and 4% ≥ four 
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children. Finally, the prevalence fi gure of 1 per 1 000 in the Finnish population ought 
to be replaced with an estimate of cumulative incidence, because the sibpairs were col-
lected over a study period of 15 years. Th e best estimate for λs from the above data is of 
the order of 15–20.
2.2 Comparison of sibling series and population-based series 
A population-based series of patients with JIA previously published in Finland (Kaipi-
ainen-Seppänen 1996) was compared with our ASP series, consisting of 80 patients 
with JIA from 37 families. Comparisons of sibling series and population-based series 
were re-calculated using only one individual (37 probands) from each sibship (Table 6). 
Distri butions of cases according to disease subtype in ASP series/ population-based 
series were similar in both series: pauciarticular onset 68% vs 70%, polyarticular onset 
27% vs 18%, enthesitis-related onset 0% vs 5%, systemic onset 5% vs 6%. Th e propor-
tion of boys was slightly higher in the sibling vs the population series (41% vs 30%). 
Uveitis and ANA-positivity were signifi cantly more frequent in the ASP series, when 
only probands were compared (32% vs 16%, p = 0.027 and 70% vs 43%, p = 0.004 re-
spectively). A further signifi cant diff erence detected was the lower age at diagnosis in 
the series of aff ected siblings (4.0 years vs 7.4 years, p < 0.001). 
Table 6 Comparison of patients with juvenile idiopathic arthritis in the sibling and popula-
tion-based series in Finland (corrected comparisons using only probands).
Variables Sibling series Population series P value
Number of patients 37 (probands) 114 
Number of boys (%) 15 (41) 34 (30) 0.23
Onset type, number (%)   0.46
 Pauciarticular 25 (68) 80 (70) 
 Polyarticular 10 (27) 21 † (18) 
 Enthesitis-related 0 (0) 6 (5) 
 Systemic 2 (5) 7 (6) 
Number of uveitis detected, n (%) 12 (32) 18 (16) 0.027
Number positive for ANA, (%) 26 (70) 49 ‡ (43) 0.004
ESR at diagnosis, (mean, SD) 40 (30) 32 (25) 0.11
Age at diagnosis, years (mean, SD) 4.0 (3.0 ) 7.4 (4.6) < 0.001
† 3 patients seropositive  ‡ information on one patient lacking
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2.3 Comparison of the Finnish versus the United States 
affected sibling pair series
Th e Finnish JIA-aff ected sibling series and the series from the United States published 
by Moroldo and colleagues (1997) were compared. Th e disease subtypes were re-
classifi ed using the same classifi cation of disease types as used in the American study. 
For comparative purposes, two enthesitis-related arthritis cases were included in our 
series in the oligoarthritis group, and one psoriatic arthritis case and one RF-positive 
polyarthritis case were included in the common polyarthritis group.
Th e Finnish series consisted of 49 ASPs and the number of American ASPs recruited 
through the JRA-ASP registry was 71. Some diff erences between these series emerged. 
First, there were somewhat more cases with oligoarthritis (71% vs 61%) and fewer with 
polyarthritis (25% vs 34%) in our series. Th e mean age at onset of the disease in the 
United States series was 5.3 years; that at diagnosis in our series was 4.8 years. Th e 
proportion of girls in the United States series was signifi cantly higher (84% vs 61%, 
p < 0.001) than in ours. 
2.4 Phenotype concordance rates
2.4.1 Finnish affected sibling pairs
In the Finnish sibling series 49% of the pairs were concordant for sex; most (71%) were 
female pairs; 57% were concordant for onset type and 89% of these were pauciarticular 
pairs. Onset type diff ered from course type in 20% of patients. Concordance by course 
type was 61%; 53% of the pairs were pauciarticular and 47% polyarticular. Concord-
ances for individual sibling pairs are presented in Table 7. Among the 6 families with 
Table 7 Comparison of similarity of 49 aff ected sibpairs according to certain characteritics.
 Concordant for  Concordant
 presence of characteristic Discordant for absence
Characteristic N (%) N (%) N ( %)
Sex (male) 7 (14) 25 (51) 17 (35)
Uveitis 3 (6) 17 (35) 29 (59)
ANA positivity 21 (43) 15 (31) 13 (27)
HLA B27 positivity 14 (29) 7 (14) 28 (57)
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3 aff ected sibs, 2 of the trios were concordant for onset type and 3 were concordant for 
course type. 
2.4.2 Concordance rate variations in the Finnish series
In the Finnish series there was no diff erence with regard to onset type and a small diff er-
ence with regard to course type. Concordance for ANA positivity was somewhat higher 
than expected; among the ANA-positive cases (56%) in the series, one would expect 
about 15 to have an ANA-positive sib. We observed 21 pairs concordant for ANA posi-
tivity. Th e concordance for the presence of uveitis was 3, not diff erent from the expected 
fi gure of 3.4.
4 Occurrence of uveitis in sibpairs (IV)
Th is study examined the prevalence of uveitis in familial JIA and found no increase in 
concordance. Uveitis was diagnosed in 21 (26%) of the 80 patients. Th e corresponding 
fi gure among the girls was 10/49 (20%) and 11/31 (35%) for boys. Oligoarthritis was the 
most frequent type of JIA (67%), and ANA positivity was common (67%) among the 
patients with uveitis derived from the whole sibling series. Th ree pairs were concordant 
for the presence of asymptomatic uveitis, the expected number being 3,4.
Th e comparisons of patients with and without uveitis were re-computed using only 
probands from sibling series (shown in Table 8). Th ere were more boys in the group 
with uveitis, and frequencies of ANA-positive and HLA B27-positive cases were also 
higher in this group. Th e mean age at diagnosis of JIA was lower in patients with uveitis. 
However, the diff erences were not statistically signifi cant. 
In four patients (19%) uveitis was found before the diagnosis of JIA, two of these 
having enthesitis-related arthritis with episodes of acute unilateral uveitis, preceding 
the onset of joint symptoms. In two patients also asymptomatic uveitis preceded arth-
ritis. In all the other patients with uveitis the eye disease appeared within fi ve years from 
the onset of arthritis.
During the routine diagnostic procedure at the hospital the patients had been 
typed by serological methods for HLA B27. Th e occurrence of this allele in familiality-
corrected results (only one proband per family used in comparisons) was somewhat 
more frequent in patients with uveitis than in those without (42% vs 32% p = 0.72) com-
pared to 14.5% in the Finnish population. Interestingly, all siblings concordant for the 
presence of asymptomatic uveitis were HLA B27-positive. None of the 16 typed patients 
with uveitis carried the allele DRB1*1104 (a split of HLA DR5), which in some studies 
has been reported to occur more frequently in patients with chronic uveitis. Six of the 
16 typed patients with uveitis, however, carried the DR1 allele (DRB1*0101), a gene 
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which in some studies has been claimed to be ‘protective’ against eye disease. Obviously, 
the number of patients with uveitis in our series was too small to draw conclusions re-
garding HLA associations. Patients with uveitis were somewhat younger at the onset of 
JIA than those without (3.6 yr vs 4.2 yr).
5 Parents of the affected sibpairs (V)
Among the collected ‘multicase families’, 9 parents from 8 families also had a diagnosis 
of chronic infl ammatory rheumatic disease. Th eir disease phenotypes (fi rst symptoms 
and age at onset of the disease) and HLA haplotypes, which are series of alleles at closely 
linked marker loci residing on the same chromosomal copy and tend to be transmitted 
intact, are shown in Table 9.
Both cases with a spondyloarthropathy diagnosis were positive for the HLA allele 
B27. Two of the three cases with juvenile oligoarthritis or polyarthritis were positive 
for HLA A2 and one was positive for HLA DR8 (alleles with an increased prevalence 
in JIA). All four cases with chronic peripheral arthritis with onset in adulthood were 
positive for HLA A2 and two were positive for HLA DR8. One case (that with uveitis 
commencing in childhood) possessed the allele HLA DR4.
Table 8 Comparisons of JIA patients from sibling series based on probands with and 
without uveitis.
 JIA patients  
Variables With uveitis Without uveitis P value
Number of patients, n (%) 12 (32%) 25 (68%) 
Boys/girls, n 7/5 8/17 0.16
Onset type of arthritis
 oligoarthritis, n (%) 8 (67%) 17 (68%) 0.99
 polyarthritis, n 3 7
 systemic, n 1 1
 enthesitis-related, n 0 0 
Positive for ANA, n (%) 11 (92%) 15 (60%) 0.064
Positive for HLA B27, n (%) 5 (42%) 8 (32%) 0.72
Age at diagnosis of arthritis, 
yrs, mean (SD) 3.6 (2.0) 4.2 (3.4) 0.55
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Table 9 Th e disease phenotypes of 9 parents with chronic arthritis. 
Family Parent Disease
Haplotype:
 A B C DR DQ
1 Father RF-neg JIA (oligo)
Both knees (10 yr)
a: 0201   3901   1203   1201   0301 
b: 0101   0801   0701   0301   0201
2 Mother RF-neg JIA (poly)
Both knees and left  ankle (5 yr)
Progression to chronic polyarthritis
c: 0201   4002   0202   1101   0301 
d: 0301   4001   0304   0801   0402
3 Mother RF-neg JIA (poly)
Knees and ankles (9 yr)
Progression to asymmetric 
polyarthritis, secondary amyloidosis 
c: 0301   0801   0701   0401   0302 
d: 2402   4001   0304   1302   0604
4 Father RF-neg JIA/SPA
Monoarthritis of the left  knee (3 yr)
In adulthood: back pains
X-ray: bilateral sacroilitis
a: 0201   2705   0202   0801   0402 
b: 2402   4402   0701   1101   0301 
4 Mother RF-neg RA
Fingers and toes, left  wrist (35 yr)
Symmetric, erosive polyarthritis
c: 0201   4001   0304   1302   0602 
d: 0301   0702   0702   1501   0604
5 Mother RF-neg oligoarthritis
Knees (27 yr)
Chronic uveitis since the age of 10
c: 0301   1501   0303   0401   0302 
d: 0201   4001   0304   0801   0402
6 Mother RF-neg oligoarthritis
Knees (25 yr)
c: 0201   1302   0602   0901   0303 
d: 0301   3501   0401   0101   0501
7 Father RF-neg oligoarthritis
Knees (54 yr)
Positive for ANA
a: 2402   3901   0702   0801   0402 
b: 0201   5601   0102   1301   0603
8 Mother SPA
X-rays verifi ed bilateral sacroilitis 
(35 yr), fi bromyalgia
c: 2501   1801   1202   1101   0301
d: 0201   2705   0202   0801   0402
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Th e pedigrees of the families are shown in Figures 3 and 4, with the index case indi-
cated by an arrow. In these eight families 19 children were aff ected by JIA; the relation-
ships in these families are shown in Figure 3–4.
Figure 3 Th e pedigrees of families 1–5 with infl ammatory arthritis among the parents of 
JIA-aff ected sibpairs. Chromosome 6 haplotypes (a,b,c,d) as described in Table 9.
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In family seven the aff ected father had three off spring aff ected by chronic arthritis 
and three second-degree relatives aff ected by JIA. In this family the haplotype distribu-
tion among the father and his 18 off sspring was not as expected (the paternal a and b 
haplotypes should have an equal (50 : 50) change to be transmitted to the children). Th e 
same phenomenom is noted in family four, where in addition all fi ve off spring are hap-
loidentical, but only two of them are aff ected.
6 Family-based HLA-association study of affected sibpairs (VI)
Signifi cantly increased HLA allele frequencies among the aff ected siblings were observed 
for HLA alleles Cw4 and DR8 (Table 10). In original publication VI the esti mation of 
allele frequencies without taking account of the relationships of aff ected siblings may 
involve a risk of biased results. Th e correction of dependence of family members by 
removal of other than propands from cases gave an even more signifi cant increased DR 
8 allele frequency among aff ected probands compared to controls. Th e frequency of the 
allele DR4 in JIA probands was signifi cantly lower than that in bone marrow donors. 
Th e prevalence of DR5 did not diff er from that in controls. DQ allele frequencies could 
not be compared because frequencies in controls were not available.
Table 10 Odds ratios and 95% CI’s of HLA C, B and DR alleles with signifi cant diff erence 
in allele frequencies between the Finnish JIA patients and Finnish bone marrow 
donors (comparison of frequencies using only one proband/family (37 probands, 
74 alleles). 
HLA  Finnish Odds ratio Odds ratio
Allele JIA cases, % population, % (95% CI) (95% CI)†
Cw4 29.7 18.6 1.85 (1.1 to 3.1) 1.7 (1.2–2.4)
Cw6  2.7 9.4 0.27 (0.03–1.0) 0.3 (0.1–0.7)
B27 13.5 8.0 1.80 (0.8–3.5) 1.8 (1.1–2.8)
B35 23.0 14.2 1.80 (0.98–3.2) 1.7 (1.1–2.4)
DR2 6.8 15.1 0.41 (0.13–1.0) 0.4 (0.2–0.7)
DR4 1.4 14.1 0.08 (0.0–0.48) 0.3(0.1–0.6)
DR8 32.4 10.4 4.14 (2.4–6.9) 3.7 (2.6–5.3)
† Th e odds ratios from original study VI with all aff ected cases/family (83 patient, 166 allele)
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Th e sharing of parental haplotypes was studied among the aff ected sibpairs (Table 11). 
Th e observed ratio of sharing 0, 1 or 2 HLA haplotypes was 10 : 23 : 17, which did not 
diff er signifi cantly from that expected. When stratifi ed by onset type, course type and 
age diff erence at onset of disease, the sharing of HLA haplotypes identical-by-descent 
was somewhat greater in concordant compared to discordant pairs, but none of the dif-
ferences was statistically signifi cant.
Of the 57 (23 + 17 + 17) shared haplotypes the most common (16%) was A*0301, 
Cw4*0401, B*3501, DRB1*0101, DQB1*0501. In 12% the shared haplotype was A*0201, 
Cw2*0202, B*2705, DRB1*0801, DQB1*0402. Of the 57 shared haplotypes 24 (42%) 
contained the DRB1*0801/DQB1*0402 combination. Twenty-three of the ASPs shared 
one common haplotype; 15 of these were maternal and in eight cases the haplotype was 
of paternal origin.
Th e Transmission Disequilibrium Test was fi rst used and showed signifi cantly in-
creased transmissions for HLA DRB1*0801, DQB1*0402 and Cw4*0401 aft er Bonfer-
roni correction. Transmissions of Cw7*0701 and DQB1*0302 alleles were signifi cantly 
decreased. Family-based multi-allelic tests for association of locus showed a statistically 
highly signifi cant association with the DR and DQ locus (p = 0.001 and p = 0.001). 
Th e association of the C locus was of borderline signifi cance (p = 0.057). Results of the 
Table 11 Haplotype sharing (identical-by-descent) in patients with JIA stratifi ed by onset 
and course type, and by age diff erence at onset of disease. 
  Haplotype sharing observed 
 
No of
 0 1 2
Group pairs N (%) N (%) N (%) P value
Total observed 50 10 (20) 23 (46) 17 (34) 0.33
By onset type
 Concordant  30 4 (13) 14 (47) 12 (40) 0.12
 Discordant 20 6 (30) 9 (45) 5 (25) 0.96
By course type
 Concordant  32 8 (25) 13 (41) 11 (34) 0.47
 Discordant  18 2 (11) 10 (56) 6 (33) 0.42
By age diff erence 
 < 2 years 25 5 (20) 9 (36) 11 (44) 0.10
 ≥ 2 years 25 5 (20) 14 (56) 6 (24) 0.81
Abbreviations: Each ASP is expected to share identical-by-descent 0, 1and 2 alleles with respective probabilities of 25%, 50% 
and 25%. 
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multiallelic test for allelic associations were comparable to those obtained with the in-
dependent-TDT (Table 12).
Th e joint allelic main eff ects of the HLA A, C, B, DR and DQ loci using the family-
based association test were analysed to provide support for the hypothesis that the allelic 
eff ects of the HLA A, C, B, DR and DQ loci are independent of each other. No signifi -
cant positive eff ects were detected at the A and B loci. At the C locus Cw4*0401 evinced 
a positive association (p = 0.001) and Cw7*0701 a negative association (p = 0.003). At 
the DRB1 locus, DRB1*0801 (p < 0.001) and DRB1*0101(p = 0.021) were positively 
associ ated with JIA, while DRB1*0301(p = 0.011) and DRB1*0401 (p = 0.022) showed 
a negative association with JIA. At the DQB1 locus positive associations were observed 
for DQB1*0402 (p < 0.001) and for DQB1*0501 (p = 0.015) and negative associations 
for DQB1*0302 (p < 0.001) and for DQB1*0201 (p = 0.012) when looking for independ-
ent eff ects.
Table 12 Locus-specifi c univariate allelic associations using the family-based association 
test in Finnish families with JIA.
 Allele Informative  P from
HLA allele frequency families Z FBAT
C*0401 0.210 13 2.62 0.009
C*0701 0.133 14 −2.27 0.024
B*3501 0.176 13 1.98 0.047
DRB1*0101 0.202 12 1.95 0.052
DRB1*0801 0.196 16 3.84 < 0.001
DQB1*0201 0.078 8 −2.08 0.037
DQB1*0302 0.098 9 −2.89 0.004
DQB1*0402 0.195 16 3.84 < 0.001
DQB1*0501 0.201 11 2.10  0.035
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Discussion
1 The Finnish population structure
Th e current Finnish population represents an isolated population descending from 
small founder populations. Th e vast majority of Finns descend from two imigration 
waves, the earlier wave involved eastern Uralic speakers about 4000 years ago, sub-
sequently followed by the migration of Indo-European speakers from the south about 
2000 years ago (Nevanlinna 1972, Norio 1981). Although the Finnish language belongs 
to the Finno-Ugric group, the Finnish gene pool is mainly European, and recent studies 
on mitochondrial DNA sequences have revealed that European populations, including 
Finns, are part of one homogeneous mitochondrial gene pool (Lahermo et al. 1996). 
However, Y-chromosome studies have revealed the contribution of two distinct male 
lineages to the present Finnish population, a paternal genetic contribution of Europeans 
and also of Asians (Kittles et al. 1998).
Th e initial founding population has undergone several bottlenecks, the most recent 
being a fall to 250 000 at the beginning of the 1700s (de la Chapelle 1993). For linguis-
tic, cultural and geographical reasons the Finnish population expanded without mixing 
with other populations. Also migration from one rural community to another has until 
recently been rare in Finland. Due to this isolation, some disease genes carried by the 
founders remained enriched and some others were lost. 
A population with founder eff ects is better suited for genetic studies than an ethni-
cally mixed population. Because the genetic material is derived from a small number of 
founders, individuals in isolated populations (founder populations) are more likely to 
carry fewer susceptibility genes than individuals in mixed populations. If the popula-
tion is relatively young, linkage disequilibrium, i.e. non-random association of alleles at 
closely linked loci, can extend for larger chromosomal intervals than in heterogeneous 
populations (Varilo et al. 1996).
2 Variable disease expression and allele frequency variations 
in the Finnish population 
Diff erences in the occurrence of the diseases between regions and countries generate a 
hypothesis regarding environmental and genetic factors which may infl uence the dis-
ease. Some regional diff erences and changes in certain common diseases, for example 
prevalence variations of coronary heart disease (Näyhä 1989), type I diabetes (Karvo-
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nen et al. 1997) and schizophrenia (Hovatta et al. 1997) have been reported in Finland. 
Most convincingly there exists a high-risk area of multiple sclerosis with exceptional 
familial clustering of cases in Western Finland (Kinnunen et al. 1983).
Allele frequencies are known to vary widely within and between populations, ir-
respective of disease status (Th e International HapMap Consortium 2005). HLA stud-
ies among healthy voluntary donors registered with the Finnish Bone Marrow Donor 
Registry indicate the existence of specifi c Finnish frequencies and some variations in 
the frequencies of the HLA antigen have also been reported, e.g., concerning antigens 
A9, B12, B35, Cw4 and DR3 (Siren et al.1996). HLA-B27 occurs in the Finnish popula-
tion more frequently (14.5%) than in most other European populations, but no regional 
diff erences have been reported. In unselected Finnish patients with JIA, the prevalence 
of HLA-B27 has been 27–36% (Kunnamo et al. 1986; Savolainen et al. 1998) and its oc-
currence is of the same order of magnitude among patients with RA in Finland (Isomäki 
et al. 1975; Paimela et al. 1993) 
When cases and contols have diff erent allele frequencies attributable to diversity in 
the background population, it emphasizes the potential for false positive results in case-
control studies. Th e positive associations observed may be a result of population stratifi -
cation (Cardon and Palmer 2003). Association studies for candidate susceptibility genes 
in JIA have revealed signifi cant variations between diff erent ethnic groups in the disease 
association of specifi c alleles. Specially non-HLA polymorphisms associations with JIA 
have not been as reproducible in diff erent populations as studies of HLA associations 
(Rosen et al. 2003) In order to limit this source of error, family-based studies and tests 
which control for population structure are essential and have been used widely. How-
ever, the availability of patients for family-based studies may lead to a risk of bias due 
to smaller materials. 
3 Selection of the patient material in the current study
3.1 Selection of controls for case-control association studies
Th e possibility of false-positive allele associations in our study is small. Allele frequen-
cies in the controls were derived from the genetically relatively homogeneous Finnish 
population and the number of healthy bone marrow donors used was large, 14 752, and 
derived from all parts of the country, thus representing frequencies in the Finnish back-
ground population without any signifi cant regional accumulations.
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3.2 Patients in family-based studies
Family-based methods such as TDT are useful particularly when working with a pedi-
atric population where parents are easily available. TDT depends on both linkage and 
association and diff ers from association tests in that the frequency of the marker alleles 
is well controlled for ethnic ancestry and is not subject to the bias introduced in con-
ventional association studies. Th e weakness of TDT and other aff ected family-based 
methods is that these lose power rapidly when the test locus is not very tightly linked 
with the true susceptibility locus, i.e. it relies heavily on linkage disequilibrium. Th is 
problem may be largely overcome if the study is based on a founder population. TDT 
does not take into account the aff ection status of the parents, which may limit its useful-
ness.
3.3 Independency of family members 
Comparisons of sibling series and population-based series were fi rst examined with 
cases identifi ed by complete ascertainment. Th e use of all siblings may have a burden 
of family ascertainment and thus the result was also computed where familiality was 
taken into account using only the fi rst ascertained case in the family. In comparison 
of sibling and population-based series the detected statistical signifi cant diff erence in 
respect of age at diagnosis remained and correction of dependence of family members 
in comparison of HLA allele frequencies between Finnish JIA patients and Finnish bone 
marrow donors gave an even more signifi cant increased DR8 allele frequency among af-
fected probands compared to controls. An important improvement in allele frequency 
estimates may be obtained by the appropriate use of data on all individuals, but the ideal 
method would be a combination of family-specifi c estimates, using weights inversely 
proportional to the variances (Broman 2001).
3.4 Possible selection of the sibling series 
from the patients treated in the Rheumatism Foundation Hospital 
Th e care of patients with JIA in Finland is markedly centralized to the Rheumatism 
Foundation Hospital, which means that almost all severe cases of JIA in the country at-
tend the hospital and are also constantly monitored there. Milder cases visit the hospital 
less frequently. According to the statistics of the Finnish Social Insurance Institution 
(estimation on the basis of the drug reimbursement register), the total number of chil-
dren with JIA is approximately 1 200 in the population of about one million children 
in Finland. According to the patient register of the Rheumatism Foundation Hospital it 
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could be estimated that about 60% of JIA patients are seen at the hospital. Our sibling 
series was probably selected but only slightly so; some ASPs with a mild disease treated 
in other hospitals might be missing from our series. 
3.5 Possible selection of patients 
in other published affected sibling pair series
Th ree studies have been published from other populations concerning JIA ASPs: two are 
from the United States: those by Suciu-Foca et al. (1980) and by Moroldo et al. (1997), 
and one is from Germany and England (Clemens et al. 1985). Suciu-Foca and Clem-
ens did not provide information on selection criteria. ASPs in the study by Moroldo 
were collected by means of a multiple advertising campaign directed to United States 
physicians likely to care for patients with Juvenile arthriris. Some diff erences emerged 
between the US and the Finnish series. First, the frequency of oligoarthritis tended to be 
higher and that of polyarthritis lower in our series. Th e reason for this is either that the 
US series was biased toward clinical cases with more severe disease, or that the patient 
clientele in Finland diff ers to some degree from that in the US. Second, there was more 
intra-pair similarity in the onset and course types among the US patients than among 
Finnish patients. A possible explanation is a selection bias toward cases resembling each 
other in the US series.
4 Magnitude of the genetic component 
in juvenile idiopathic arthritis
4.1 Sibling recurrence risk
Th e degree of familial clustering is one measure of the genetic component in disease. It 
is estimated from the risk of disease between two comparison populations; the preva-
lence of disease in fi rst-degree relatives of the patients compared to the prevalence in the 
population (Risch, 1990). Th e genetic contribution to RA is quite small according to the 
sibling recurrence risk (λs) estimate in RA, which is about 4 (range 2–5) (Silman 2001, 
del Junco et al. 1984). Th e magnitude of the contribution of HLA to overall genetic 
risk in RA is probabbly around one third of the total (Deighton et al. 1989; Seldin et al. 
1999), with a λs HLA estimate about 1.8 (Jawaheer et al. 2001). 
It has proved problematic to estimate the genetic contribution to JIA, as the number 
of families with multiple cases has been limited. In addition, the prevalence of the dis-
ease depends on its clinical defi nition. JIA is not one distinct disease but a group of 
clinical syndromes. Glass and Giannini (1999) suggested a λs for JIA of 15, although 
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their basic fi gures were not in accordance with this (estimated number of ASPs 300; 
prevalence of JIA in pediatric population about 1 per 1 000, U.S. population 250 mil-
lion). Th e λs HLA DR accounted for about 17% of the risk of JRA (Prahalad et al. 2000/a). 
Our estimate of λs from the collected study data is of the order of about 15–20, which 
has also been estimated for type I diabetes and multiple sclerosis. (Harjutsalo et al 2005, 
Lindsey 2005).
4.2 Concordance rate in twins
Th e comparison of MZ and DZ twins provides an extension to separate the infl uence 
of genetic and environmental risk factors in disease. A disease with a higher concord-
ance rate in MZ compared to DZ twins is assumed to have a genetic component. Th e 
concordance rate in MZ twins observed in two population-based surveys of RA twins 
varied from 12% (Aho et al. 1986) to15% (Silman et al. 1993), around four times greater 
than seen in DZ twins. 
Under the assumption that MZ and DZ twins share environmental factors equally, 
the comparison of concordance rates in MZ and DZ twins can be used to derive an 
estimate of heritability. Heritability is the proportion of the variance in the disease liabil-
ity which can be explained by genetic variance (Wright et al. 2003). From the afore-
mentioned twin studies (Aho et al. 1986, Silman et al. 1993) the heritability of RA has 
been estimated to be about 60% (MacGregor et al. 2000). Th e discordance (i.e. pheno-
typic diff erences) among genetically identical MZ twins has usually been attributed to 
the eff ects of non-shared environment, but may also be an example of epigenetic regula-
tion during cell diff erentation and embryonic morphogenesis (Wong et al. 2005)
Th e concordance rate cannot be computed from the American JIA twin study fi g-
ures. In a study by Prahalad and associates (2000/b), 14 pairs of twins were identifi ed in 
which both twins have arthritis. Th irteen pairs (11 MZ twin pairs) were concordant for 
disease type (Prahalad et al. 2000/b). 
Th e concordance rate can be expressed as either a pairwise or a probandwise rate, 
depending on the concordant pairs ascertained. In probandwise estimation both mem-
bers of the twin pairs are ascertained independently and twin pairs are counted twice, 
while pairwise concordance rate estimation uses concordant twinships identifi ed by 
complete ascertainment, in which every pair is counted only once. Within our study 
series of 2 000 JIA patients there were eight sets of MZ twins, two of which were con-
cordant for JIA. Both sets of twins were concordant for course type but diff erent for 
onset type (Study 1). A pairwise concordance rate of 25% for a disease with a population 
prevalence of 1 per 1000 implies a relative risk of 250 for a MZ twin, while probandwise 
concordance 4/10 implies an even higher relative risk. Th is concordance rate is very 
similar to that found for type 1 diabetes in a nationwide series of Finnish twins (Hytti-
nen et al. 2003).
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5 Familial disease, evidence for a stronger genetic background?
In certain common diseases there may be small genetically determined subsets. In some 
instances, but not always, they diff er clinically from sporadic disease. A proportion of 
breast cancers develop as a result of inherited predisposition genes, with BRCA1 and 
BRCA2 accounting for the majority of these genes (Lux et al. 2005). Other diseases 
such as familial adenomatous polyposis colorectal cancer and a subset of non-polyposis 
colorectal cancer are dominantly inherited and in both of these gene mutations have 
been already identifi ed (Aaltonen 2000). Th ese cancers diff er from sporadic forms by 
an earlier age of onset, by some clinical manisfestations and by having a family history 
of colorectal and/or other extra-intestinal cancers.
Additionally, familial forms of Alzheimer’s disease, aff ecting approximately 10% of 
patients (Haass and Baumeister 1998), and Parkinson´s disease (Gasser 2001) have been 
identifi ed. Patients are younger at disease onset, and have more aff ected fi rst-degree 
relatives.
Diff erences between familial and sporadic RA have been looked for in many previ-
ous studies. Basically the disease is clinically the same and associated with the same 
genetic risk factors. Th e diff erent relative risks are explained by comparison of HLA 
DR4 frequency between familial and non-familial RA patients; the eff ect of DR4 seems 
to be larger in multicase families than in sporadic cases (Laivoranta-Nyman 2000). Th e 
only clinical diff erence is a tendency to earlier age at disease onset in familial compared 
to non-familial RA (Kwoh et al. 1996; Laivoranta-Nyman 2000). 
Diff erences between sporadic and familial JIA were for the fi rst time compared by 
Moroldo and colleagues (1997). Clinical features of the disease within the various sub-
types appeared to be similar in both populations. Comparisons of Finnish sibling series 
with a Finnish population-based series (Study III) were corrected by taking into account 
the dependence of family members. Comparison of only the propands to population-
based series revealed that uveitis and ANA positivity were signifi cantly more frequent 
in ASP series and a tendency to earlier age at the disease onset in familial JIA was noted. 
Th e HLA allele distributions between familial and sporadic JIA patients could not be 
compared as there were no HLA data available on Finnish sporadic JIA patients.
6 Genetic component in uveitis
Chronic uveitis occurs most commonly in patients with persistent oligoarthritis, espe-
cially in young girls with early onset disease. Th is extra-articular manifestation is also 
frequently seen in patients with RF-negative polyarthritis, whereas it only seldom oc-
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curs in systemic disease. Th e position of chronic uveitis in the classifi cation scheme of 
JIA is not clear; it may represent a separate entity, irrespective of the type of arthritis 
accompanying its course.
Histocompatibility allele profi les have been studied in uveitis associated with early-
onset oligoarthritis. In two American series, the HLA allele DRB1*1104 (a split of HLA 
DR5) occurred signifi cantly more frequently in patients with chronic uveitis than in 
those not suff ering from the disorder (Malagon et al. 1992; Melin-Aldana et al. 1992). 
No corresponding diff erence emerged in a patient series collected in Central Europe 
(Haas et al. 1994). In all three series, the frequency of the allele DRB1*01 was reduced. 
Data on HLA allele distributions in chronic uveitis associated with other forms of JIA 
have not been published, probably due to the small number of cases available.
Th e main purpose of this present study was to assess the concordance rate of uveitis 
in ASPs. Hereby a higher than expected concordance rate would point to the existence 
of a genetic component of its own for uveitis. However, our data combined with fi gures 
from two earlier series (Clemens et al. 1985; Moroldo et al. 1997) did not provide sup-
port for this contention. 
Nonetheless, the fi ndings do not rule out a modest association with some genetic 
marker (genotype relative risk), provided that its frequency is fairly high. Th is is because 
the frequency of a common genetic marker is not appreciably higher among siblings of 
patients with uveitis than in the general population and, accordingly, a modest genotype 
relative risk adds little to the sibling recurrence ratio (del Junco et al. 1984).
7 Increase in occurrence of chronic infl ammatory rheumatic 
disease among the parents of affected sibling pairs
Th e diff erent subtypes of JIA are based primarily on clinical characteristics and most 
of the disease subtypes in children are considered as being diff erent from adult cases. 
Th ere are nonetheless subtypes which on the basis of clinical characteristics and im-
munogenetic profi le may be related to adult rheumatic diseases. Systemic JIA and adult 
onset Still’s disease represent the same disease entity on the basis of clinical features 
of the diseases. Enthesitis-related arthritis and RF-positive polyarthritis appear to be 
childhood counterparts of spondyloarthropathy and RA, respectively. A proportion of 
RF-negative polyarthritis is possibly related to RF-negative RA in adults, on the basis 
of a proposed genetic link (Gao et al. 1991). A subtype of oligoarthritis oft en associated 
with chronic anterior uveitis and ANA positivity is considered to be a subtype existing 
exclusively in children.
Previous family studies of JIA patients and fi rst-degree relatives have demonstrated 
a higher than expected prevalence of spondyloarthropathy (Hertzberger-ten Cate and 
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Dijkmans 1993) and psoriasis (Andersson Gäre and Fasth 1995). Our aim was to deter-
mine the frequency of chronic rheumatic infl ammatory diseases among the parents in 
multicase families, where the disease genes are assumed to be accumulated.
Th e prevalence of JIA in children of North European ancestry is about 1 per 1 000 
(Andersson Gäre 1999). Since the mean age at falling ill is 7–8 years, the cumulative 
incidence of JIA in adults is about 2 per 1 000. In the present study, one could expect 
about 0.2 cases among the 90 parents of the children. However, a marked increase in the 
JIA cases among the parents of JIA ASPs was noted; four cases were found. In addition 
there were four cases of RF-negative chronic peripheral arthritis with onset of disease 
in adulthood. One of these satisfi ed the ACR criteria for RA (Arnett et al. 1988), and 
three had RF-negative oligoarthritis, i.e. resembling oligoarticular JIA. Th ese fi ndings 
provided evidence for the existence of a JIA of adult onset. HLA fi ndings on adult cases 
of chronic peripheral arthritis supported this contention.
HLA fi ndings in adult onset chronic peripheral arthritis cases were compatible with 
earlier reported HLA associations with oligoarticular JIA. All cases were positive for 
HLA A2 and two were also positive for HLA DR8. One case (the patient with uveitis 
commencing in childhood) possessed the allele HLA DR4 (expected prevalence). In 
this series we did not study the HLA DP locus, but in earlier studies, HLA DPB1*0301 
has been found to be a risk factor for both polyarticular JIA and for RF-negative adult 
RA (Gao et al.1991).
Accumulation of JIA-type diseases in two generations supports our earlier conten-
tion that the genetic component in JIA is higher than previously believed (Study II).
8 HLA association and linkage studies 
in juvenile idiopathic arthritis
JIA is not one distinct disease but a group of syndromes including several diseases with 
heterogeneous etiologies and with diff erent reported genetic associations. RF-positive 
polyarthritis, psoriatic arthritis and enthesitis-related arthritis have their counterparts 
in adults and available evidence is in accordance with the view that these subsets have 
the same genetic basis as the diseases commencing in adulthood. Oligoarticular disease 
and RF-negative polyarthritis are the most common subsets of JIA. Th ey have been re-
ported to be associated with certain alleles at the HLA A, C, B, DR/DQ and DP loci. A 
characteristic feature of JIA is the interaction of these HLA genes within the same locus 
or between diff erent loci, each having a small and additive eff ect (Forre and Smerdel, 
2002).
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8.1 Population-based association study
Previously published studies of sporadic JIA have mainly relied on association methods 
in non-founder populations, which are problematic due to the uncertain contribution 
of population admixture. Th e reported associations carry the risk of generating biased 
results for many reasons, e.g., population stratifi cation (Cardon and Palmer 2003). To 
date, only one study from 1978 has been published dealing with the HLA allele distri-
bution in Finnish JIA patients (this includes only HLA A and B alleles) (Mäkelä and 
Tiilikainen 1978). Th e present is the fi rst study describing whole HLA haplotypes in 
Finnish JIA patients. We looked at the HLA allele distribution in our sibling series at 
HLA loci A, C, B and DR. Th e study sample was too small to carry out separate analyses 
by JIA subgroups. Based on the entire study material, signifi cantly increased HLA allele 
frequencies among the aff ected siblings compared to control cases were found for the 
HLA-Cw4, -B27, -B35 and -DR8 alleles; that with DR8 was the strongest. Th ese HLA 
alleles also have been found to be increased in some earlier studies in other populations 
(Howard et al. 1985; Murray et al. 1999; Forre and Smerdel 2002).
8.2 Linkage to HLA detected by family-based HLA haplotype sharing 
Nonparametric linkage studies such as haplotype sharing among aff ected siblings are 
the traditional means of assessing linkage. Th ey have, however, a limited statistical 
power to detect linkage if genetic associations are weak and each susceptibility locus in 
the haplotype provides only a limited relative risk.
Two small sibling series detailing haplotype sharing (Suciu-Foca et al. 1980; Clemens 
et al. 1985) and a larger one on allele sharing (Prahalad et al. 2000/a) in JIA have been 
published. A marked excess of shared haplotypes was recorded in the very small series 
of Clemens and associates (1985). Prahalad and group (2000/a) focused their study on 
the DR locus, this being believed to be the major HLA locus determining susceptibility 
to JIA. According to their paper aff ected siblings only had been tested, no other family 
members. Th us, information on identity by descent could not be obtained. Based on 
statistics designed for identity by state, the authors showed a signifi cant excess of shar-
ing 0, 1 or 2 DR alleles: 8 : 40 : 32, instead of the expected ratio of 20 : 40 : 20 (p < 0.001). 
Th e authors computed a sibling recurrence risk of 2.5 for the DR locus. 
In addition to aff ected siblings, we here typed all the parents and most of the un-
aff ected sibs. Th is family-based approach enabled an unambiguous defi nition of haplo-
type and allele sharing by descent in each instance. Th e observed ratio of sharing 0, 
1 and 2 HLA haplotypes (A, C, B, DR and DQ) was 10 : 23 : 17, statistically not sig-
nifi cantly diff erent from that expected, although there was a tendency to an increase 
in HLA-identical siblings. Th e relatively high number of HLA non-identical siblings 
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among these ASPs may suggest that one parent carried not only one but both HLA 
haplotypes which conferred the susceptibility to JIA, or that both parents carried sus-
ceptibility haplotypes, although diff erent ones. 
8.3 Linkage in the presence of association
Th e TDT test confi rmed linkage in the presence of association. Aside from the current 
study, linkage to HLA has been confi rmed in TDT studies of JIA nuclear families with 
only one aff ected (single cases) in three populations, in American pauciarticular onset 
JRA patients, according to ARA criteria (Moroldo et al. 1998), in UK Caucasian JIA pa-
tients, according to ILAR classifi cation (Zeggini et al. 2002) and in Finnish JIA patients 
with oligoarticular and RF-negative polyarticular subtypes (Runstadler et al. 2003).
Th e family-based association test was used to test association in the presence of link-
age between HLA markers and any gene infl uencing JIA. Th e association analysis of 
HLA A, C, B, DR and DQ by independent TDT test and by family-based association 
tests now confi rmed in the Finnish population that the most signifi cant associations 
prevailed for DRB1*0801, DQB1*0402, as expected from previous observations, and 
also supported an independent role of Cw*0401.
8.4 HLA associations in juvenile idiopathic arthritis 
Unlike adult RA, which has a strong association with HLA DRB1*0401, JIA shows a 
pattern of more polygenic inheritance. A characteristic feature of JIA is the interaction 
of HLA genes, which increases the risk of the disease (Forre and Smerdel 2002). Some 
HLA associations are due to linkage disequilibrium between markers involved, but ac-
cumulating evidence indicates that several diff erent genes in the HLA region are impli-
cated in the pathogenesis of JIA (Zeggini et al. 2002). It will thus be diffi  cult to assess 
the independent role of diff erent HLA loci, alleles and haplotypes contributing to the 
genetic component associated with the HLA region, although this would be important 
for understanding the etiology of the disease.
9 What do we know, what we need to know
Th e HLA region probably represents only a modest fraction in the overall genetic com-
ponent of JIA. Most of the fi ndings of non-HLA gene associations are unconfi rmed. It is 
reasonable to assume that new information will accumulate, in part based on progress 
in genome-wide screening techniques or on fi ndings achieved by in vitro stimulation of 
63
cytokine production, which, however, do not always correspond to the situation in vivo. 
Accordingly, it would be important to extend patient series and in the case of JIA ASP 
series international co-operation will be needed.
Th e aim of genetic studies is to make the determination of genetic markers available 
for clinical practice and useful for tailoring treatment schedules. Only little is known 
about what factors are predictive of outcome of JIA. Th e phenotype, e.g. the disease sub-
type, certainly plays a role. At the moment there are no good means to diff erentiate in 
the early phase between children with a progressive course of their disease and children 
who have the genetic make-up associated with mild disease and should not be exposed 
to possible toxic side eff ects of medical treatment.
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Conclusions
1 Th e genetic component in JIA seems to be greater than previously estimated, and 
greater than that in adult-onset RA. Th e best estimate for the sibling recurrence risk 
was 15–20.
2 Th e comparison of population-based JIA series and ASP series and the HLA associ-
ations among sibling series suggested that genetically familial and sporadic JIA pa-
tients represent the same disease.
3 Th e concordance rate for uveitis in sibling pairs with JIA was of the same order of 
magnitude as expected by chance. Th us, chronic uveitis in JIA patients has no spe-
cifi c genetic component of its own to separate these from other JIA patients.
4 Parents in families of multiple off spring aff ected with JIA had a markedly increased 
frequency of chronic infl ammatory arthritis, either JIA or a similar type of disease 
(in most instances RF-negative oligoarthritis) commencing in adulthood. Th is can 
be taken as evidence for the existence of adult-onset JIA. 
5 Haplotype sharing analysis showed a tendency towards increased sharing of com-
mon haplotypes, but this did not reach the level of statistical signifi cance. Th e TDT 
and FBAT analyses provided evidence for genetic linkage between the HLA region 
and JIA and further evidence for a major contribution of HLA genes to genetic sus-
ceptibility to JIA. Th e association analysis of HLA A, C, B, DR and DQ alleles by 
both TDT and FBAT tests now confi rmed in the Finnish population that the most 
signifi cant associations prevailed for DRB1*0801, DQB1*0402, as expected from 
previous observations, and also supported the independent role of Cw*0401.
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